<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Corticosteroids for pneumonia - Stern, A - 2017 | Cochrane Library</title> <meta content="Corticosteroids for pneumonia - Stern, A - 2017 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007720.pub3/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Corticosteroids for pneumonia - Stern, A - 2017 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007720.pub3/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD007720.pub3" name="dc.identifier" scheme="DOI"/> <meta content="Corticosteroids for pneumonia" name="citation_title"/> <meta content="Anat Stern" name="citation_author"/> <meta content="Rambam Health Care Campus" name="citation_author_institution"/> <meta content="a_shteren@rambam.health.gov.il" name="citation_author_email"/> <meta content="Keren Skalsky" name="citation_author"/> <meta content="Beilinson Hospital, Rabin Medical Center" name="citation_author_institution"/> <meta content="Tomer Avni" name="citation_author"/> <meta content="Beilinson Hospital, Rabin Medical Center" name="citation_author_institution"/> <meta content="Elena Carrara" name="citation_author"/> <meta content="Policlinico San Matteo Hospital" name="citation_author_institution"/> <meta content="Leonard Leibovici" name="citation_author"/> <meta content="Beilinson Hospital, Rabin Medical Center" name="citation_author_institution"/> <meta content="Mical Paul" name="citation_author"/> <meta content="Rambam Health Care Campus" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="12" name="citation_issue"/> <meta content="10.1002/14651858.CD007720.pub3" name="citation_doi"/> <meta content="2017" name="citation_date"/> <meta content="2017/12/13" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007720.pub3/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007720.pub3/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007720.pub3/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Adrenal Cortex Hormones [adverse effects, *therapeutic use]; Ampicillin [adverse effects, therapeutic use]; Anti‐Bacterial Agents [therapeutic use]; Budesonide [adverse effects, therapeutic use]; Dexamethasone [adverse effects, therapeutic use]; Hydrocortisone [adverse effects, therapeutic use]; Pneumonia [*drug therapy, mortality]; Prednisolone [adverse effects, therapeutic use]; Randomized Controlled Trials as Topic" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007720.pub3&amp;doi=10.1002/14651858.CD007720.pub3&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007720.pub3&amp;doi=10.1002/14651858.CD007720.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007720.pub3&amp;doi=10.1002/14651858.CD007720.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007720.pub3&amp;doi=10.1002/14651858.CD007720.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007720.pub3&amp;doi=10.1002/14651858.CD007720.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007720.pub3&amp;doi=10.1002/14651858.CD007720.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007720.pub3&amp;doi=10.1002/14651858.CD007720.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007720.pub3&amp;doi=10.1002/14651858.CD007720.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007720.pub3&amp;doi=10.1002/14651858.CD007720.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007720.pub3&amp;doi=10.1002/14651858.CD007720.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007720.pub3&amp;doi=10.1002/14651858.CD007720.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007720.pub3&amp;doi=10.1002/14651858.CD007720.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007720.pub3&amp;doi=10.1002/14651858.CD007720.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007720.pub3&amp;doi=10.1002/14651858.CD007720.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007720.pub3&amp;doi=10.1002/14651858.CD007720.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007720.pub3&amp;doi=10.1002/14651858.CD007720.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007720.pub3&amp;doi=10.1002/14651858.CD007720.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007720.pub3&amp;doi=10.1002/14651858.CD007720.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007720.pub3&amp;doi=10.1002/14651858.CD007720.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007720.pub3&amp;doi=10.1002/14651858.CD007720.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007720.pub3&amp;doi=10.1002/14651858.CD007720.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007720.pub3&amp;doi=10.1002/14651858.CD007720.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007720.pub3&amp;doi=10.1002/14651858.CD007720.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="9mpoajSI";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD007720\x2epub3\x26doi\x3d10\x2e1002\x2f14651858\x2eCD007720\x2epub3\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007720\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007720\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","zh_HANT","fr","pt","zh_HANS","fa","ms"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD007720.pub3",title:"Corticosteroids for pneumonia",firstPublishedDate:"Dec 13, 2017 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Acute Respiratory Infections Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=9mpoajSI&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD007720.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD007720.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD007720.pub3/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD007720.pub3/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD007720.pub3%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD007720.PUB3" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;pt&quot;,&quot;title&quot;:&quot;Resumo&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pt&quot;,&quot;title&quot;:&quot;Resumo para leigos&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;Plain language summary&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Conclusiones de los autores&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Antecedentes&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Objetivos&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Métodos&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Discusión&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD007720.pub3/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD007720.PUB3" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD007720.pub3/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD007720.pub3/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>38490 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD007720.pub3" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007720.pub3/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007720.pub3/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007720.pub3/full#CD007720-abs-0004"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007720.pub3/full#CD007720-sec-0117"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007720.pub3/full#CD007720-sec-0043"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007720.pub3/full#CD007720-sec-0044"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007720.pub3/full#CD007720-sec-0049"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007720.pub3/full#CD007720-sec-0050"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007720.pub3/full#CD007720-sec-0073"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007720.pub3/full#CD007720-sec-0111"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007720.pub3/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007720.pub3/appendices#CD007720-sec-0122"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007720.pub3/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007720.pub3/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/table_n/CD007720StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/table_n/CD007720StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007720.pub3/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007720.pub3/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007720.pub3/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD007720.pub3/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD007720.pub3/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD007720.pub3/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2017 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> <div class="inline-status-wrapper"> <ul class="cochrane-status"> <li aria-label="A new search for studies has been conducted." class="status-item up-to-date custom-tooltip" data-status="newsearch" title="A new search for studies has been conducted."> <a class="btn secondary" href="information#history">New search</a> </li> <li aria-label="There has been an important change to the conclusions of the review." class="status-item up-to-date custom-tooltip" data-status="conclusionchanged" title="There has been an important change to the conclusions of the review."> <a class="btn secondary" href="information#history">Conclusions changed</a> </li> </ul> </div> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Corticosteroids for pneumonia</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD007720.pub3/information#CD007720-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Anat Stern</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD007720.pub3/information#CD007720-cr-0003">Keren Skalsky</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD007720.pub3/information#CD007720-cr-0004">Tomer Avni</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD007720.pub3/information#CD007720-cr-0005">Elena Carrara</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD007720.pub3/information#CD007720-cr-0006">Leonard Leibovici</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD007720.pub3/information#CD007720-cr-0007">Mical Paul</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/information/en#CD007720-sec-0129">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 13 December 2017 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD007720.pub3">https://doi.org/10.1002/14651858.CD007720.pub3</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD007720-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD007720-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD007720-abs-0003">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD007720-abs-0012">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD007720-abs-0002">Français</a> </li> <li class="section-language"> <a class="" href="full/pt#CD007720-abs-0008">Português</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD007720-abs-0010">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD007720-abs-0001" lang="en"> <section id="CD007720-sec-0001"> <h3 class="title" id="CD007720-sec-0001">Background</h3> <p>Pneumonia is a common and potentially serious illness. Corticosteroids have been suggested for the treatment of different types of infection, however their role in the treatment of pneumonia remains unclear. This is an update of a review published in 2011. </p> </section> <section id="CD007720-sec-0002"> <h3 class="title" id="CD007720-sec-0002">Objectives</h3> <p>To assess the efficacy and safety of corticosteroids in the treatment of pneumonia.</p> </section> <section id="CD007720-sec-0003"> <h3 class="title" id="CD007720-sec-0003">Search methods</h3> <p>We searched the Cochrane Acute Respiratory Infections Group's Specialised Register, CENTRAL, MEDLINE, Embase, and LILACS on 3 March 2017, together with relevant conference proceedings and references of identified trials. We also searched three trials registers for ongoing and unpublished trials. </p> </section> <section id="CD007720-sec-0004"> <h3 class="title" id="CD007720-sec-0004">Selection criteria</h3> <p>We included randomised controlled trials (RCTs) that assessed systemic corticosteroid therapy, given as adjunct to antibiotic treatment, versus placebo or no corticosteroids for adults and children with pneumonia. </p> </section> <section id="CD007720-sec-0005"> <h3 class="title" id="CD007720-sec-0005">Data collection and analysis</h3> <p>We used standard methodological procedures expected by Cochrane. Two review authors independently assessed risk of bias and extracted data. We contacted study authors for additional information. We estimated risk ratios (RR) with 95% confidence intervals (CI) and pooled data using the Mantel–Haenszel fixed‐effect model when possible. </p> </section> <section id="CD007720-sec-0006"> <h3 class="title" id="CD007720-sec-0006">Main results</h3> <p>We included 17 RCTs comprising a total of 2264 participants; 13 RCTs included 1954 adult participants, and four RCTs included 310 children. This update included 12 new studies, excluded one previously included study, and excluded five new trials. One trial awaits classification. </p> <p>All trials limited inclusion to inpatients with community‐acquired pneumonia (CAP), with or without healthcare‐associated pneumonia (HCAP). We assessed the risk of selection bias and attrition bias as low or unclear overall. We assessed performance bias risk as low for nine trials, unclear for one trial, and high for seven trials. We assessed reporting bias risk as low for three trials and high for the remaining 14 trials. </p> <p>Corticosteroids significantly reduced mortality in adults with severe pneumonia (RR 0.58, 95% CI 0.40 to 0.84; moderate‐quality evidence), but not in adults with non‐severe pneumonia (RR 0.95, 95% CI 0.45 to 2.00). Early clinical failure rates (defined as death from any cause, radiographic progression, or clinical instability at day 5 to 8) were significantly reduced with corticosteroids in people with severe and non‐severe pneumonia (RR 0.32, 95% CI 0.15 to 0.7; and RR 0.68, 95% CI 0.56 to 0.83, respectively; high‐quality evidence). Corstocosteroids reduced time to clinical cure, length of hospital and intensive care unit stays, development of respiratory failure or shock not present at pneumonia onset, and rates of pneumonia complications. </p> <p>Among children with bacterial pneumonia, corticosteroids reduced early clinical failure rates (defined as for adults, RR 0.41, 95% CI 0.24 to 0.70; high‐quality evidence) based on two small, clinically heterogeneous trials, and reduced time to clinical cure. </p> <p>Hyperglycaemia was significantly more common in adults treated with corticosteroids (RR 1.72, 95% CI 1.38 to 2.14). There were no significant differences between corticosteroid‐treated people and controls for other adverse events or secondary infections (RR 1.19, 95% CI 0.73 to 1.93). </p> </section> <section id="CD007720-sec-0007"> <h3 class="title" id="CD007720-sec-0007">Authors' conclusions</h3> <p>Corticosteroid therapy reduced mortality and morbidity in adults with severe CAP; the number needed to treat for an additional beneficial outcome was 18 patients (95% CI 12 to 49) to prevent one death. Corticosteroid therapy reduced morbidity, but not mortality, for adults and children with non‐severe CAP. Corticosteroid therapy was associated with more adverse events, especially hyperglycaemia, but the harms did not seem to outweigh the benefits. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD007720-abs-0004" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD007720-abs-0004">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD007720-abs-0007">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD007720-abs-0013">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD007720-abs-0006">Français</a> </li> <li class="section-language"> <a class="" href="full/ms#CD007720-abs-0014">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pt#CD007720-abs-0009">Português</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD007720-abs-0011">简体中文</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD007720-abs-0005">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD007720-abs-0004" lang="en"> <h3>Is treatment with corticosteroids beneficial and safe for people with pneumonia?</h3> <p><b>Review question</b> </p> <p>We looked at the effects of treating people with pneumonia using corticosteroids (also called steroids or glucocorticoids) on numbers of deaths, response to treatment, treatment complications, and side effects. We compared treatment with corticosteroids in addition to antibiotics with placebo or no treatment. </p> <p><b>Background</b> </p> <p>Acute pneumonia is a lung infection treated with antibiotics that target the bacteria that caused the infection. Pneumonia is quite common, and despite adequate antibiotic treatment, complications and sometimes death can occur. </p> <p>Corticosteroids are hormones produced naturally in the adrenal gland. Corticosteroids have been found to be beneficial in the treatment of some infections. However, their beneficial effects are often offset by serious side effects, mainly when used at high doses and over the long term. This is an update of a review published in 2011. </p> <p><b>Search date</b> </p> <p>The evidence is current to 3 March 2017.</p> <p><b>Study characteristics</b> </p> <p>We included 17 studies evaluating systemic corticosteroid therapy (given intravenously or by tablets) for people with pneumonia (2264 participants; 1954 adults and 310 children). We included 12 new studies in this update and excluded one previously included study. All included studies evaluated people who had acquired pneumonia in the community (community‐acquired pneumonia (CAP)) being treated in the hospital; no studies assessed people who had developed pneumonia while in hospital or who were on breathing machines (mechanically ventilated). </p> <p><b>Study funding sources</b> </p> <p>Eight trials did not report funding sources; seven were funded by academic sponsors; one was funded by a pharmaceutical company; and one reported receiving no funding. </p> <p><b>Key results</b> </p> <p>Corticosteroids reduced deaths in adults with severe CAP, but not in people with non‐severe CAP. Eighteen adults with severe CAP need to be treated with corticosteroids to prevent one death. </p> <p>People with CAP treated with corticosteroids had lower clinical failure rates (death, worsening of imaging studies, or no clinical improvement), shorter time to cure, a shorter hospital stay, and fewer complications. We found good‐quality evidence that corticosteroids reduced clinical failure rates in children with pneumonia, but the data were based on a small number of children with different types of pneumonia. </p> <p>People treated with corticosteroids had higher blood glucose levels (hyperglycaemia) than those not treated with corticosteroids. Corticosteroid treatment was not associated with increased rates of other serious adverse events. </p> <p>Corticosteroids were beneficial for adults with severe CAP. People with non‐severe CAP may also benefit from corticosteroid therapy, but with no survival advantage. </p> <p><b>Quality of the evidence</b> </p> <p>We downgraded the quality of the evidence due to issues with study design, unclear results, or results that were not similar across studies. For the outcomes of death and clinical failure in adults, we graded the quality of the evidence as moderate. For the outcomes of clinical failure in people with severe CAP, non‐severe CAP, and in children, we graded the quality of the evidence as high. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD007720-sec-0117" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD007720-sec-0117">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD007720-sec-0159">Español</a> </li> </nav> </div> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD007720-sec-0117"></div> <h3 class="title" id="CD007720-sec-0118">Implications for practice</h3> <section id="CD007720-sec-0118"> <p>The results of this review support the use of corticosteroids in adults with severe community‐acquired pneumonia (CAP) using either the Infectious Diseases Society of America and American Thoracic Society guidelines or British Thoracic Society criteria for severe CAP. Among these patients, corticosteroids reduce mortality, clinical failure, complication rates, length of hospitalisation, and time to clinical cure. People with non‐severe CAP may benefit from corticosteroid therapy as well, but with no survival advantage. Regarding the latter, caution is required for people with diabetes due to the effect of corticosteroids on glucose control. The quality of the evidence for these conclusions is mostly moderate. Corticosteroid therapy is associated with more adverse events, especially hyperglycaemia, but the harm does not seem to outweigh the benefits. </p> <p>Regarding paediatric patients, it seems there is some advantage for corticosteroid therapy, but the low event rate of complications and the paucity of data preclude recommendation of its regular use. </p> </section> <h3 class="title" id="CD007720-sec-0119">Implications for research</h3> <section id="CD007720-sec-0119"> <p>Further research is needed to clarify the role of corticosteroid therapy in specific patient populations. There are no randomised controlled trials (RCTs) assessing the effects of corticosteroids in people with hospital‐acquired pneumonia or ventilator‐associated pneumonia, and too few RCTs have evaluated this question in paediatric patients. Other populations in which more study is required are diabetic patients, elderly patients, and those with viral pneumonia. Future trials should also evaluate the recommended dose and duration of corticosteroid therapy. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD007720-sec-0043" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD007720-sec-0043"></div> <div class="table" id="CD007720-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Corticosteroids compared to control for pneumonia</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Corticosteroids compared to control for pneumonia</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> people with community‐acquired pneumonia<br/> <b>Setting:</b> hospitalised patients<br/> <b>Intervention:</b> corticosteroids<br/> <b>Comparison:</b> control (placebo or no treatment) </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with control</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with corticosteroids</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Mortality ‐ adults</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.66<br/> (0.47 to 0.92) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1863<br/> (11 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>82 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>53 per 1000<br/> (38 to 74) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Mortality ‐ adults ‐ severe CAP</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.58<br/> (0.40 to 0.84) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>995<br/> (9 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>131 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>76 per 1000<br/> (52 to 110) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Mortality ‐ adults ‐ non‐severe CAP</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.95<br/> (0.45 to 2.00) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>868<br/> (4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>29 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>28 per 1000<br/> (13 to 58) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Early clinical failure ‐ adults</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.40<br/> (0.23 to 0.70) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1324<br/> (6 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>3 4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>373 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>149 per 1000<br/> (86 to 261) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Early clinical failure ‐ adults ‐ severe CAP</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.32<br/> (0.15 to 0.70) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>419<br/> (5 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊕<br/> HIGH <sup>5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>422 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>135 per 1000<br/> (63 to 296) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Early clinical failure ‐ adults ‐ non‐severe CAP</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.68<br/> (0.56 to 0.83) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>905<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊕<br/> HIGH </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>352 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>240 per 1000<br/> (197 to 292) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Early clinical failure ‐ children</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.41<br/> (0.24 to 0.70) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>88<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊕<br/> HIGH <sup>6 7</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>659 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>270 per 1000<br/> (158 to 461) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CAP</b> : community‐acquired pneumonia; <b>CI:</b> confidence interval; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate quality:</b> We are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low quality:</b> Our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low quality:</b> We have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of the effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Some trials had unclear allocation concealment, which seemed to exaggerate the effect of corticosteroids.<br/> <sup>2</sup>We downgraded quality for imprecision because the 95% CIs overlap no effect and the RR ranged from ‐55% to 100%.<br/> <sup>3</sup>We downgraded quality for inconsistency (I² = 89.3% for this outcome).<br/> <sup>4</sup>Some trials had unclear allocation concealment, however we did not downgrade quality because the effect of intervention remained significant in trials with low and unclear allocation concealment.<br/> <sup>5</sup>We downgraded quality for inconsistency (I² = 74% for this outcome) and upgraded one level for large effect (RR = 0.32).<br/> <sup>6</sup>We downgraded quality for risk of bias (analysis includes two low‐quality trials).<br/> <sup>7</sup>We upgraded quality one level for large effect (RR = 0.41). </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD007720-sec-0044" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD007720-sec-0044">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD007720-sec-0139">Español</a> </li> </nav> </div> </div> <section class="background" lang="en"> <div class="section-header" id="CD007720-sec-0044"></div> <section id="CD007720-sec-0045"> <h3 class="title" id="CD007720-sec-0045">Description of the condition</h3> <p>Acute pneumonia is a common and potentially serious illness. Despite significant advances in its aetiological investigation, antimicrobial therapy, and improvements in supportive care, acute pneumonia is still among the top 10 most common causes of death among all age groups. In the USA in 2013, pneumonia was the sixth‐leading cause of death in people aged 65 years and over, and the single most common cause of infection‐related mortality (<a href="./references#CD007720-bbs2-0081" title="XuJ , MurphySL , KochanekKD , BastianBA . Deaths: Final Data for 2013. National Vital Statistics Reports2016;64(2):1‐119. ">Xu 2016</a>). </p> <p>In the past, acute pneumonia was classified as community‐acquired pneumonia (CAP) and hospital‐acquired pneumonia (HAP) including ventilator‐associated pneumonia (VAP), based on differences in aetiologic agents and antibiotic susceptibilities among these entities. Following increases in healthcare delivery shifting to outpatient settings, an additional pneumonia category, healthcare‐associated pneumonia (HCAP), has been defined. Healthcare‐associated pneumonia occurs in non‐hospitalised people who have had extensive healthcare contact, defined as including one or more of: intravenous therapy, wound care, or intravenous chemotherapy over the previous 30 days; residing in a nursing home or other long‐term care facility; hospitalisation in an acute care hospital for two or more days over the previous 90 days; or attending a hospital or haemodialysis clinic over the previous 30 days (<a href="./references#CD007720-bbs2-0042" title="FriedmanND , KayeKS , StoutJE , McGarrySA , TrivetteSL , BriggsJP , et al. Health care‐associated bloodstream infections in adults: a reason to change the accepted definition of community‐acquired infections. Annals of Internal Medicine2002;137(10):791‐7. ">Friedman 2002</a>). </p> <p>The aetiology of CAP varies by geographic region. However, <i>Streptococcus pneumoniae</i> is the most common cause worldwide (<a href="./references#CD007720-bbs2-0040" title="FileTMJr , MarrieTJ . Burden of community‐acquired pneumonia in North American adults. Postgraduate Medicine2010;122(2):130‐41. ">File 2010</a>). The overall incidence of CAP in adults is approximately 5.16 to 6.11 cases per 1000 persons per year and increases with age. There is seasonal variation, with more cases of pneumonia occurring during the winter months. About 20% of all people with CAP are admitted to hospital (<a href="./references#CD007720-bbs2-0061" title="NiedermanMS . Recent advances in community‐acquired pneumonia: inpatient and outpatient. Chest2007;131(4):1205‐15. ">Niederman 2007</a>), and approximately 10% to 20% of patients require admission to intensive care units (ICU) (<a href="./references#CD007720-bbs2-0057" title="MarrieTJ , ShariatzadehMR . Community‐acquired pneumonia requiring admission to an intensive care unit: a descriptive study. Medicine2007;86(2):103‐11. ">Marrie 2007</a>; <a href="./references#CD007720-bbs2-0063" title="RestrepoMI , MortensenEM , VelezJA , FreiC , AnzuetoA . A comparative study of community‐acquired pneumonia patients admitted to the ward and the ICU. Chest2008;133(3):610‐7. ">Restrepo 2008</a>). Thirty‐day mortality in people who are hospitalised for CAP is approximately 10% to 12% and is higher in people admitted to the ICU (<a href="./references#CD007720-bbs2-0060" title="MusherDM , ThornerAR . Community‐acquired pneumonia. New England Journal of Medicine2014;271(17):1619‐28. ">Musher 2014</a>). </p> <p>HAP, VAP, and HCAP may be caused by a broad variety of pathogens and can be polymicrobial. Common pathogens include aerobic gram‐negative bacilli and gram‐positive cocci (e.g. <i>Staphylococcus aureus</i> , including methicillin‐resistant <i>S aureus</i> (MRSA) and <i>Streptococcus</i> spp). Hospital‐acquired pneumonia due to viruses or fungi is significantly less common, except in people who are immunocompromised (<a href="./references#CD007720-bbs2-0046" title="JonesRN . Microbial etiologies of hospital‐acquired bacterial pneumonia and ventilator‐associated bacterial pneumonia. Clinical Infectious Diseases2010;51(Suppl 1):S81‐7. ">Jones 2010</a>). </p> <p>Precise incidence rates of HAP and HCAP are difficult to determine because of differences in local epidemiology and infection control measures. Estimates of HAP incidence range from 5 to more than 20 episodes per 1000 hospitalisations (<a href="./references#CD007720-bbs2-0036" title="ChawlaR . Epidemiology, etiology, and diagnosis of hospital‐acquired pneumonia and ventilator‐associated pneumonia in Asian countries. American Journal of Infection Control2008;36(4 Suppl):S93‐100. ">Chawla 2008</a>), accounting for up to 25% of all nosocomial (hospital‐acquired) infections (<a href="./references#CD007720-bbs2-0053" title="MagillSS , EdwardsJR , BambergW , BeldavsZG , DumyatiG , KainerMA , et al. Emerging Infections Program Healthcare‐Associated Infections and Antimicrobial Use Prevalence Survey Team. Multistate point‐prevalence survey of health care‐associated infections. New England Journal of Medicine2014;370(13):1198‐208. ">Magill 2014</a>; <a href="./references#CD007720-bbs2-0073" title="TorresA , FerrerM , BadiaJR . Treatment guidelines and outcomes of hospital‐acquired and ventilator‐associated pneumonia. Clinical Infectious Diseases2010;51(Suppl 1):S48‐53. ">Torres 2010</a>). Hospital‐acquired pneumonia is the leading cause of death among hospital‐acquired infections, with estimates of HAP‐associated mortality ranging from 20% to 50% (<a href="./references#CD007720-bbs2-0036" title="ChawlaR . Epidemiology, etiology, and diagnosis of hospital‐acquired pneumonia and ventilator‐associated pneumonia in Asian countries. American Journal of Infection Control2008;36(4 Suppl):S93‐100. ">Chawla 2008</a>; <a href="./references#CD007720-bbs2-0067" title="RosenthalVD , BijieH , MakiDG , MehtaY , ApisarnthanarakA , MedeirosEA , et al. International Nosocomial Infection Control Consortium (INICC) report, data summary of 36 countries, for 2004‐2009. American Journal of Infection Control2012;40(5):396‐407. ">Rosenthal 2012</a>). The rate of VAP development is between 10% and 30% of patients receiving more than 48 hours of mechanical ventilation (<a href="./references#CD007720-bbs2-0067" title="RosenthalVD , BijieH , MakiDG , MehtaY , ApisarnthanarakA , MedeirosEA , et al. International Nosocomial Infection Control Consortium (INICC) report, data summary of 36 countries, for 2004‐2009. American Journal of Infection Control2012;40(5):396‐407. ">Rosenthal 2012</a>; <a href="./references#CD007720-bbs2-0073" title="TorresA , FerrerM , BadiaJR . Treatment guidelines and outcomes of hospital‐acquired and ventilator‐associated pneumonia. Clinical Infectious Diseases2010;51(Suppl 1):S48‐53. ">Torres 2010</a>). The occurrence of VAP has a significant impact on patient outcomes; it is associated with substantial morbidity, significantly longer ICU stays, and a two‐fold mortality rate compared with similar patients who do not have VAP (<a href="./references#CD007720-bbs2-0069" title="SafdarN , DezfulianC , CollardHR , SaintS . Clinical and economic consequences of ventilator‐associated pneumonia: a systematic review. Critical Care Medicine2005;33(10):2184‐93. ">Safdar 2005</a>). </p> </section> <section id="CD007720-sec-0046"> <h3 class="title" id="CD007720-sec-0046">Description of the intervention</h3> <p>Corticosteroids (glucocorticoids, steroids) include steroid hormones that are naturally produced in the adrenal cortex of vertebrates and their synthetic analogues. Corticosteroids are involved in many physiological processes, including stress response, immune response and regulation of inflammation, carbohydrate metabolism, protein catabolism, blood electrolyte levels and behaviour. Synthetic derivatives of natural steroids include prednisone, prednisolone, methylprednisolone, betamethasone, dexamethasone, triamcinolone, and hydrocortisone. Corticosteroids are important components in the treatment of many inflammatory, allergic, immunologic, and malignant disorders. Corticosteroids are administered by inhalation, orally, or intravenously (<a href="./references#CD007720-bbs2-0065" title="RhenT , CidlowskiJA . Antiinflammatory action of glucocorticoids ‐ new mechanisms for old drugs. New England Journal of Medicine2005;353(16):1711‐23. ">Rhen 2005</a>). </p> <p>Unfortunately, the therapeutic effects of corticosteroids are often accompanied by clinically significant side effects, most of which are related to the dose and duration of therapy (<a href="./references#CD007720-bbs2-0065" title="RhenT , CidlowskiJA . Antiinflammatory action of glucocorticoids ‐ new mechanisms for old drugs. New England Journal of Medicine2005;353(16):1711‐23. ">Rhen 2005</a>). Many adverse effects occur only with prolonged administration; most short‐term adverse events are reversible when the drug is discontinued. Side effects observed with long‐term, high‐dose treatment include obesity with a special fat distribution pattern (e.g. face swelling), immune depression, delayed wound healing, growth retardation in children, hirsutism, diabetes, depressive disorders, Cushing’s syndrome, and osteoporosis (<a href="./references#CD007720-bbs2-0062" title="OrayM , Abu SamraK , EbrahimiadibN , MeeseH , FosterCS . Long‐term side effects of glucocorticoids. Expert Opinion on Drug Safety2016;15(4):457‐65. ">Oray 2016</a>). Short‐term use of corticosteroids may be associated with hyperglycaemia, fluid retention, and hypertension, which are typically transient (<a href="./references#CD007720-bbs2-0071" title="SchäckeH , DöckeWD , AsadullahK . Mechanisms involved in the side effects of glucocorticoids. Pharmacology &amp; Therapeutics2002;96(1):23‐43. ">Schäcke 2002</a>). Neuropsychiatric side effects, ranging from insomnia and irritability to mania, psychosis, and delirium, are commonly seen with short‐term corticosteroid use (<a href="./references#CD007720-bbs2-0078" title="WarringtonTP , BostwickJM . Psychiatric adverse effects of corticosteroids. Mayo Clinic Proceedings2006;81(10):1361‐7. ">Warrington 2006</a>). </p> </section> <section id="CD007720-sec-0047"> <h3 class="title" id="CD007720-sec-0047">How the intervention might work</h3> <p>Corticosteroids have been suggested for the treatment of different types of infections, including meningitis, tuberculosis, pneumocystis pneumonia, other bacterial pneumonia, and septic shock. The theoretical advantages of corticosteroids differ for each infection type (<a href="./references#CD007720-bbs2-0035" title="ChalmersJD , SinganayagamA , AkramAR , MandalP , ShortPM , ChoudhuryG , et al. Severity assessment tools for predicting mortality in hospitalised patients with community‐acquired pneumonia. Systematic review and meta‐analysis. Thorax2010;65(10):878‐83. ">Chalmers 2010</a>; <a href="./references#CD007720-bbs2-0047" title="KalilAC , MeterskyML , KlompasM , MuscedereJ , SweeneyDA , PalmerLB , et al. Management of adults with hospital‐acquired and ventilator‐associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clinical Infectious Diseases2016;63(5):e61‐111. ">Kalil 2016</a>; <a href="./references#CD007720-bbs2-0070" title="SalluhJI , PóvoaP , SoaresM , Castro‐Faria‐NetoHC , BozzaFA , BozzaPT . The role of corticosteroids in severe community‐acquired pneumonia: a systematic review. Critical Care2008;12(3):R76. ">Salluh 2008</a>). </p> <p>In septic shock, a condition of extreme physiological stress, suboptimal cortisol production has been termed critical illness‐related corticosteroid insufficiency (CIRCI) (<a href="./references#CD007720-bbs2-0056" title="MarikPE , PastoresSM , AnnaneD , MeduriGU , SprungCL , ArltW , et al. American College of Critical Care Medicine. Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: consensus statements from an international task force by the American College of Critical Care Medicine. Critical Care Medicine2008;36(6):1937‐49. ">Marik 2008</a>). The major theoretical purpose of corticosteroids in sepsis is to restore balance to the altered hypothalamic‐pituitary‐adrenal axis (<a href="./references#CD007720-bbs2-0029" title="AnnaneD , BellissantE , BollaertPE , BriegelJ , KehD , KupferY . Corticosteroids for severe sepsis and septic shock: a systematic review and meta‐analysis. BMJ2004;329(7464):480. ">Annane 2004</a>; <a href="./references#CD007720-bbs2-0055" title="EllisonRT3rd , DonowitzGR . Acute pneumonia. In: MandellGL , BennettJE editor(s). Mandell, Douglas and Bennett's Principles and Practice of Infectious Diseases. 8th Edition. Vol. 1, London: Churchill Livingstone, 2015:823‐46. ">Mandell 2015</a>). People with pneumonia might present with CIRCI, requiring corticosteroid support. In addition, corticosteroids might have a local effect at the site of infection in pneumonia. In pulmonary infections, the release of cytokines and other inflammatory mediators from alveolar macrophages serves as a useful mechanism to eliminate invading pathogens. However, excessive release can potentially be harmful to the lung and the host. Corticosteroids might reduce pulmonary inflammation in severe pneumonia, preventing respiratory failure (<a href="./references#CD007720-bbs2-0055" title="EllisonRT3rd , DonowitzGR . Acute pneumonia. In: MandellGL , BennettJE editor(s). Mandell, Douglas and Bennett's Principles and Practice of Infectious Diseases. 8th Edition. Vol. 1, London: Churchill Livingstone, 2015:823‐46. ">Mandell 2015</a>). Several in vitro studies have demonstrated that corticosteroids decrease cytokine expression in human cells and inhibit migration of phagocytic cells (<a href="./references#CD007720-bbs2-0065" title="RhenT , CidlowskiJA . Antiinflammatory action of glucocorticoids ‐ new mechanisms for old drugs. New England Journal of Medicine2005;353(16):1711‐23. ">Rhen 2005</a>). It has been shown that corticosteroids also diminish the release of cytokines (mainly interleukin‐6 (IL‐6) in serum and broncho‐alveolar lavage) in vivo, and that C‐reactive protein (an acute‐phase protein related to IL‐6) and neutrophil counts in broncho‐alveolar aspirates were decreased in people receiving corticosteroids. Possible explanations for the latter include the effect of corticosteroids on neutrophil migration or accelerated neutrophil apoptosis in a cytokine‐depleted milieu, or both (<a href="./references#CD007720-bbs2-0020" title="MontónC , EwigS , TorresA , El‐EbiaryM , FilellaX , RañóA , et al. Role of glucocorticoids on inflammatory response in nonimmunosuppressed patients with pneumonia: a pilot study. European Respiratory Journal1999;14(1):218‐20. ">Montón 1999</a>). Another potential benefit of corticosteroids in pneumonia is by blocking a Jarisch‐Herxheimer–like reaction to initiation of antibiotics in patients with high bacterial load. The Jarisch‐Herxheimer–like reaction is thought to be due to high concentrations of cytokines shortly after initiation of antibiotics, possibly through release of endotoxin or other bacterial mediators in people with a high bacterial burden (<a href="./references#CD007720-bbs2-0080" title="WunderinkRG . Corticosteroids for severe community‐acquired pneumonia: not for everyone. JAMA2015;313(7):673‐4. ">Wunderink 2015</a>). This is the probable mechanism underlying the benefit of corticosteroids in meningococcal meningitis (<a href="./references#CD007720-bbs2-0033" title="BrouwerMC , McIntyreP , PrasadK , van deBeekD . Corticosteroids for acute bacterial meningitis. Cochrane Database of Systematic Reviews2015, Issue 9. [DOI: 10.1002/14651858.CD004405.pub5] ">Brouwer 2015</a>). </p> <p>The possible benefits of corticosteroid therapy must be balanced against their potential adverse effects. Hyperglycaemia is known to be associated with poor clinical outcomes in critically ill patients. Several trials have shown that hyperglycaemic critically ill patients have higher mortality rates than those who are normoglycaemic, although a causal relationship has not been proved (<a href="./references#CD007720-bbs2-0049" title="KrinsleyJS . Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. Mayo Clinic Proceedings2003;78(12):1471. ">Krinsley 2003</a>). Fluid retention as an adverse effect of corticosteroid therapy with resulting pulmonary congestion may also have deleterious effects in people with pneumonia, especially those with severe pneumonia or acute respiratory distress syndrome (ARDS). Other common adverse effects of short‐term corticosteroid therapy may be more relevant to milder cases of pneumonia, for example development of delirium may result in prolongation of hospital stay, and insomnia might affect patients' quality of life. Systemic glucocorticoid therapy is associated with a dose‐dependent increase in the risk of infection, especially with common bacterial, viral, and fungal pathogens. Specifically, in high‐dose glucocorticoid therapy there is an immediate risk of infection due to inhibitory effects on phagocytic cell function. Most clinical trials evaluating the role of corticosteroids in pneumonia used short courses of relatively low‐dose corticosteroids, which are not expected to pose a significant infection risk. </p> </section> <section id="CD007720-sec-0048"> <h3 class="title" id="CD007720-sec-0048">Why it is important to do this review</h3> <p>In clinical practice, use of corticosteroids for people with pneumonia remains variable. Current guidelines do not address corticosteroids in the standard management of people with CAP, HAP, HCAP, or VAP (<a href="./references#CD007720-bbs2-0047" title="KalilAC , MeterskyML , KlompasM , MuscedereJ , SweeneyDA , PalmerLB , et al. Management of adults with hospital‐acquired and ventilator‐associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clinical Infectious Diseases2016;63(5):e61‐111. ">Kalil 2016</a>; <a href="./references#CD007720-bbs2-0054" title="MandellLA , WunderinkRG , AnzuetoA , BartlettJG , CampbellGD , DeanNC , et al. Infectious Diseases Society of America. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community‐acquired pneumonia in adults. Clinical Infectious Diseases2007;44(Suppl 2):S27‐72. ">Mandell 2007</a>). An exception is the British guidelines, which state that "... steroids are not recommended in the routine treatment of high severity CAP" (<a href="./references#CD007720-bbs2-0052" title="LimWS , BaudouinSV , GeorgeRC , HillAT , JamiesonC , LeJeuneI , et al. Pneumonia Guidelines Committee of the BTS Standards of Care Committee. BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax2009;64(Suppl 3):iii1. ">Lim 2009</a>). </p> <p>The 2011 version of this Cochrane Review showed that corticosteroids were beneficial for accelerating the time to resolution of symptoms with no effect on mortality for most people with pneumonia (<a href="./references#CD007720-bbs2-0082" title="ChenY , LiK , PuH , WuT . Corticosteroids for pneumonia. Cochrane Database of Systematic Reviews2011, Issue 3. [DOI: 10.1002/14651858.CD007720.pub2] ">Chen 2011</a>). Since then, several relatively large randomised controlled trials assessing the role of corticosteroids for people with pneumonia have been published. Combining data from all relevant trials may lead to more definitive conclusions, particularly whether the effects of corticosteroids could be patient‐specific. Compiling all existing studies might allow for the assessment of corticosteroid effects for specific patient subgroups with pneumonia. For this update we revised the protocol, inclusion criteria, and analyses and re‐extracted all data. We have reported deviations from the original review, <a href="./references#CD007720-bbs2-0082" title="ChenY , LiK , PuH , WuT . Corticosteroids for pneumonia. Cochrane Database of Systematic Reviews2011, Issue 3. [DOI: 10.1002/14651858.CD007720.pub2] ">Chen 2011</a>, in the <a href="#CD007720-sec-0133">Differences between protocol and review</a> section of this update. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD007720-sec-0049" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD007720-sec-0049">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD007720-sec-0144">Español</a> </li> </nav> </div> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD007720-sec-0049"></div> <p>To assess the efficacy and safety of corticosteroids in the treatment of pneumonia. In particular, we aimed to answer whether systemic steroid treatment: </p> <p> <ol id="CD007720-list-0001"> <li> <p>reduces all‐cause mortality among people with pneumonia;</p> </li> <li> <p>reduces morbidity among people with pneumonia;</p> </li> <li> <p>increases complication rates among people with pneumonia.</p> </li> </ol> </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD007720-sec-0050" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD007720-sec-0050">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD007720-sec-0145">Español</a> </li> </nav> </div> </div> <section class="methods" lang="en"> <div class="section-header" id="CD007720-sec-0050"></div> <section id="CD007720-sec-0051"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD007720-sec-0052"> <h4 class="title">Types of studies</h4> <p>Randomised controlled trials assessing the effectiveness of corticosteroids for pneumonia were eligible for inclusion. </p> </section> <section id="CD007720-sec-0053"> <h4 class="title">Types of participants</h4> <p>Adults or children with radiographically confirmed pneumonia, including community‐acquired pneumonia (CAP) treated in the community, hospitals, or intensive care unit (ICU); healthcare‐associated pneumonia (HCAP); hospital‐acquired pneumonia (HAP); and ventilator‐associated pneumonia (VAP). </p> <p>We excluded studies including only neonates, people with <i>Pneumocystis</i> pneumonia, and people with HIV. </p> </section> <section id="CD007720-sec-0054"> <h4 class="title">Types of interventions</h4> <p>Systemic corticosteroid treatment, given as adjunct to antibiotic treatment versus antibiotics alone or antibiotics with placebo. Corticosteroids may have been given at any dose, mode, and for any duration. We included the following corticosteroids: prednisone, prednisolone, methylprednisolone, betamethasone, dexamethasone, triamcinolone, and hydrocortisone. </p> </section> <section id="CD007720-sec-0055"> <h4 class="title">Types of outcome measures</h4> <section id="CD007720-sec-0056"> <h5 class="title">Primary outcomes</h5> <p> <ol id="CD007720-list-0002"> <li> <p>All‐cause mortality within 30 days after randomisation. If not reported at day 30, we extracted the outcome closest to 30 days. </p> </li> </ol> </p> </section> <section id="CD007720-sec-0057"> <h5 class="title">Secondary outcomes</h5> <p> <ol id="CD007720-list-0003"> <li> <p>Early clinical failure (clinical failure at 5 to 7 days), defined as death from any cause, radiographic progression, or clinical instability, as defined in the study. We accepted the study definitions and assessed their compatibility with the outcome suggested by the Infectious Diseases Society of America (IDSA), that is at least one of the following: temperature higher than 37.8 °C, heart rate higher than 100 beats per minute, respiratory rate higher than 24 breaths per minute, systolic blood pressure lower than 90 mm Hg or need for vasopressor support, altered mental status, inability for oral intake, or inadequate oxygenation at room temperature (PaO₂ &lt; 60 mm Hg or pulse oximetry &lt; 90%) (<a href="./references#CD007720-bbs2-0054" title="MandellLA , WunderinkRG , AnzuetoA , BartlettJG , CampbellGD , DeanNC , et al. Infectious Diseases Society of America. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community‐acquired pneumonia in adults. Clinical Infectious Diseases2007;44(Suppl 2):S27‐72. ">Mandell 2007</a>). </p> </li> <li> <p>Time to clinical cure, defined at least by no fever, haemodynamic stability, and return to baseline respiratory condition. We accepted the study definitions for clinical cure, recorded them, and assessed their compatibility with the IDSA outcome definitions. </p> </li> <li> <p>Development of respiratory failure not present initially, defined as need for non‐invasive or invasive mechanical ventilation that was not present at onset of pneumonia. </p> </li> <li> <p>Development of shock not present initially.</p> </li> <li> <p>Transfer to ICU among participants not admitted initially to the ICU.</p> </li> <li> <p>Duration of hospital stay for hospitalised participants.</p> </li> <li> <p>Duration of ICU stay for participants admitted to the ICU.</p> </li> <li> <p>Pneumonia complications not present initially, including empyema, lung abscess, pneumothorax (as defined in study). </p> </li> <li> <p>Secondary infections, including any superinfection diagnosed ≥ 72 hours from randomisation.</p> </li> <li> <p>Adverse events:</p> <ul id="CD007720-list-0004"> <li> <p>any adverse event;</p> </li> <li> <p>hyperglycaemia, preferably defined as new need for insulin treatment;</p> </li> <li> <p>neuropsychiatric events, including delirium;</p> </li> <li> <p>gastrointestinal bleeding; and</p> </li> <li> <p>adverse cardiac events, including arrhythmia, congestive heart failure exacerbation, or acute coronary event. </p> </li> </ul> </li> </ol> </p> </section> </section> </section> <section id="CD007720-sec-0058"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD007720-sec-0059"> <h4 class="title">Electronic searches</h4> <p>The previous version of this review included trials identified from searches of the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, Embase, the China National Knowledge Infrastructure (CNKI) and VIP databases up to 2010 (<a href="./references#CD007720-bbs2-0082" title="ChenY , LiK , PuH , WuT . Corticosteroids for pneumonia. Cochrane Database of Systematic Reviews2011, Issue 3. [DOI: 10.1002/14651858.CD007720.pub2] ">Chen 2011</a>). </p> <p>For this update, we searched the Cochrane Central Register of Controlled Trials (CENTRAL; 2017, Issue 2) which includes the Cochrane Acute Respiratory Infections Group's Specialised Register (searched 2 March 2017), MEDLINE Ovid (1946 to 2 March 2017), Embase (Elsevier) (1974 to 3 March 2017), and LILACS (Latin American and Caribbean Health Sciences Literature) (BIREME) (1982 to 3 March 2017). We did not search the China National Knowledge Infrastructure (CNKI) and VIP databases due to lack of search experts with Chinese language knowledge, but we did consider articles identified in the previous search. </p> <p>We used the search strategy described in <a href="./appendices#CD007720-sec-0123">Appendix 1</a> to search MEDLINE and CENTRAL. We combined the MEDLINE search with the Cochrane Highly Sensitive Search Strategy for identifying randomised trials in MEDLINE: sensitivity‐ and precision‐maximising version (2008 revision); Ovid format (<a href="./references#CD007720-bbs2-0051" title="LefebvreC , ManheimerE , GlanvilleJ . Chapter 6: Searching for studies. In: HigginsJP , GreenS editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Lefebvre 2011</a>). We adapted the search strategy to search Embase (<a href="./appendices#CD007720-sec-0124">Appendix 2</a>) and LILACS (<a href="./appendices#CD007720-sec-0125">Appendix 3</a>). </p> </section> <section id="CD007720-sec-0060"> <h4 class="title">Searching other resources</h4> <p>We handsearched references of all included studies for more trials. We reviewed trials included in recent systematic reviews assessing steroids for pneumonia for inclusion eligibility (<a href="./references#CD007720-bbs2-0045" title="HoritaN , OtsukaT , HaranagaS , NamkoongH , MikiM , MiyashitaN , et al. Adjunctive systemic corticosteroids for hospitalized community‐acquired pneumonia: systematic review and meta‐analysis 2015 update. Scientific Reports2015;5:14061. ">Horita 2015</a>; <a href="./references#CD007720-bbs2-0058" title="MartiC , GrosgurinO , HarbarthS , CombescureC , AbbasM , RutschmannO , et al. Adjunctive corticotherapy for community acquired pneumonia: a systematic review and meta‐analysis. PLoS ONE2015;10(12):e0144032. ">Marti 2015</a>; <a href="./references#CD007720-bbs2-0072" title="SiemieniukRA , MeadeMO , Alonso‐CoelloP , BrielM , EvaniewN , PrasadM , et al. Corticosteroid therapy for patients hospitalized with community‐acquired pneumonia: a systematic review and meta‐analysis. Annals of Internal Medicine2015;163(7):519‐28. ">Siemieniuk 2015</a>; <a href="./references#CD007720-bbs2-0077" title="WanYD , SunTW , LiuZQ , ZhangSG , WangLX , KanQC . Efficacy and safety of corticosteroids for community‐acquired pneumonia: a systematic review and meta‐analysis. Chest2016;149(1):209‐19. ">Wan 2016</a>). </p> <p>We also searched the following conference proceedings: European Congress of Clinical Microbiology and Infectious Diseases (2001 to 2016) and ICAAC/Annual Meeting of the Infectious Diseases Society of America (IDSA) (2001 to 2016) and intensive care conference proceedings. </p> <p>We searched trial registers for ongoing and unpublished trials: WHO International Clinical Trials Registry Platform (ICTRP) (<a href="http://www.who.int/ictrp/en" target="_blank">who.int/ictrp/en</a>, searched 3 March 2017), ISRCTN registry (<a href="http://www.isrctn.com/" target="_blank">www.isrctn.com</a>, searched 3 March 2017), and ClinicalTrials.gov (<a href="http://www.clinicaltrials.gov" target="_blank">www.clinicaltrials.gov</a>, searched 3 March 2017). </p> </section> </section> <section id="CD007720-sec-0061"> <h3 class="title" id="CD007720-sec-0061">Data collection and analysis</h3> <section id="CD007720-sec-0062"> <h4 class="title">Selection of studies</h4> <p>Two review authors (AS, KS) independently screened titles and abstracts for inclusion of all potential studies identified as a result of the search. </p> <p>We retrieved full‐text study reports, and two review authors (AS, KS) independently screened the full texts to identify studies for inclusion and recorded reasons for exclusion of the ineligible studies. Any disagreements were resolved by discussion or by consulting a third review author (MP). We identified and excluded duplicates and planned to collate multiple reports of the same study so that each study, rather than each report, was the unit of interest in the review. We did not use any language or publication status restrictions. We recorded the selection process in a PRISMA flow diagram and <a href="./references#CD007720-sec-0136" title="">Characteristics of excluded studies</a> tables (<a href="./references#CD007720-bbs2-0059" title="MoherD , LiberatiA , TetzlaffJ , AltmanDG , PRISMA Group. Preferred reporting items for systematic reviews and meta‐analyses: the PRISMA statement. Annals of Internal Medicine2009;151(4):264‐9. ">Moher 2009</a>). </p> </section> <section id="CD007720-sec-0063"> <h4 class="title">Data extraction and management</h4> <p>We used a data collection form for study characteristics and outcome data that had been piloted. Two review authors (AS and KS or EC) independently extracted study characteristics from the included studies. We extracted the following study characteristics. </p> <p> <ol id="CD007720-list-0005"> <li> <p>Methods: study design, total duration of study, details of any 'run in' period, number of study centres and location, study setting, withdrawals, and date of study. </p> </li> <li> <p>Participants: N, mean age, severity of condition, comorbidities, inclusion criteria, and exclusion criteria. </p> </li> <li> <p>Interventions: intervention, comparison, concomitant antibiotic therapy, and excluded medications. </p> </li> <li> <p>Outcomes: primary and secondary outcomes specified and collected, and time points reported. </p> </li> <li> <p>Notes: funding for trial, and notable conflicts of interest of trial authors.</p> </li> </ol> </p> <p>Two review authors (AS, KS or EC) independently extracted outcome data from the included studies. We planned to note in the <a href="./references#CD007720-sec-0135" title="">Characteristics of included studies</a> table if outcome data were not reported in a usable way. Any disagreements were resolved by consensus or by involving a third review author (MP or LL). One review author (AS) transferred data into the Review Manager 5 file (<a href="./references#CD007720-bbs2-0064" title="Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">Review Manager 2014</a>). We double‐checked that data were entered correctly by comparing the data presented in the systematic review with the study reports. A second review author (MP) spot‐checked study characteristics for accuracy against the trial report. </p> </section> <section id="CD007720-sec-0064"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors (AS, KS) independently assessed risk of bias for each study using the criteria outlined in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD007720-bbs2-0044" title="HigginsJP , GreenS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a>). Any disagreements were resolved by discussion or by involving another review author (MP). We assessed risk of bias according to the following domains. </p> <p> <ol id="CD007720-list-0006"> <li> <p>Random sequence generation.</p> </li> <li> <p>Allocation concealment.</p> </li> <li> <p>Blinding of participants and personnel.</p> </li> <li> <p>Blinding of outcome assessment.</p> </li> <li> <p>Incomplete outcome data.</p> </li> <li> <p>Selective outcome reporting.</p> </li> <li> <p>Other bias.</p> </li> </ol> </p> <p>We graded each potential source of bias as high, low, or unclear and provided quotes from the study report together with a justification for our judgement in the 'Risk of bias' table. We summarised the 'Risk of bias' judgements across different studies for each of the domains listed. We considered blinding separately for different key outcomes where necessary. Where information on risk of bias related to unpublished data or correspondence with a trialist, we noted this in the 'Risk of bias' table. </p> <p>When considering treatment effects, we took into account the risk of bias for the studies that contributed to that outcome. </p> </section> <section id="CD007720-sec-0065"> <h4 class="title">Measures of treatment effect</h4> <p>We entered outcome data for each study into the data tables in Review Manager 5 to calculate the treatment effects (<a href="./references#CD007720-bbs2-0064" title="Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">Review Manager 2014</a>). We used risk ratios for dichotomous outcomes and absolute mean differences for continuous outcomes (time to and durations). When means and standard deviations were not provided for the continuous outcomes in the primary studies, we estimated the means and standard deviations from the reported figures (medians, interquartile ranges) to enable meta‐analysis, using the methods described by <a href="./references#CD007720-bbs2-0076" title="WanX , WangW , LiuJ , TongT . Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Medical Research Methodology2014;14:135. [DOI: 10.1186/1471‐2288‐14‐135] ">Wan 2014</a>. </p> </section> <section id="CD007720-sec-0066"> <h4 class="title">Dealing with missing data</h4> <p>We contacted investigators to verify key study characteristics and obtain missing numerical outcome data. Where this was not possible, and the missing data were thought to introduce serious bias, we explored the impact of including these studies in the overall assessment of results by a sensitivity analysis. </p> <p>Where numerical outcome data were missing and could not be obtained from the authors, we calculated data from other available statistics such as P values according to the methods described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD007720-bbs2-0044" title="HigginsJP , GreenS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a>). </p> </section> <section id="CD007720-sec-0067"> <h4 class="title">Assessment of heterogeneity</h4> <p>We used the I² statistic to measure heterogeneity among the trials in each analysis. Where we identified substantial heterogeneity, we reported this with details from our exploration of possible causes according to prespecified subgroup analysis. </p> </section> <section id="CD007720-sec-0068"> <h4 class="title">Assessment of reporting biases</h4> <p>We planned that if we were able to pool more than 10 trials, we would create and examine a funnel plot to explore possible small‐study and publication biases. </p> </section> <section id="CD007720-sec-0069"> <h4 class="title">Data synthesis</h4> <p>We undertook meta‐analyses where more than one study provided usable data in any single comparison, only where this was meaningful, that is if the treatments, participants, and the underlying clinical question were sufficiently similar and clinically homogeneous for pooling to make sense. We pooled risk ratios (RRs) and mean differences (MDs) with 95% confidence intervals (CIs). As we observed no events in all trials for the analysis of mortality in children, we pooled risk differences (RDs) to estimate the 95% CIs of no difference between arms. We assumed clinical heterogeneity, and initially applied the random‐effects model to all meta‐analyses. However, as results of the fixed‐effect and random‐effects models were similar, we used a fixed‐effect meta‐analysis to summarise the best estimate of the intervention effect, given that most meta‐analyses included few studies and so as not exaggerate the contribution of small studies (<a href="./references#CD007720-bbs2-0044" title="HigginsJP , GreenS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a>). </p> <p>We performed data analysis using Review Manager 5 software (<a href="./references#CD007720-bbs2-0064" title="Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">Review Manager 2014</a>). </p> <section id="CD007720-sec-0070"> <h5 class="title">GRADE and 'Summary of findings' table</h5> <p>We created a 'Summary of findings' table using the following outcomes: mortality and early clinical failure<i>.</i> We used the five GRADE considerations (study limitations, consistency of effect, imprecision, indirectness, and publication bias) to assess the quality of a body of evidence as it relates to the studies that contribute data to the meta‐analyses for the prespecified outcomes (<a href="./references#CD007720-bbs2-0031" title="AtkinsD , BestD , BrissPA , EcclesM , Falck‐YtterY , FlottorpS , et al. GRADE Working Group. Grading quality of evidence and strength of recommendations. BMJ2004;328(7454):1490. ">Atkins 2004</a>). We used methods and recommendations described in Section 8.5 and Chapter 12 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD007720-bbs2-0044" title="HigginsJP , GreenS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a>), employing GRADEpro GDT software (<a href="./references#CD007720-bbs2-0043" title="GRADE Working Group, McMaster University. GRADEpro GDT. Version (accessed prior to 30 August 2017). Hamilton (ON): GRADE Working Group, McMaster University, 2015. ">GRADEpro GDT 2015</a>). We downgraded the evidence from 'high quality' by one level for serious, and by two levels for very serious study limitations or risk of bias, indirectness of evidence, inconsistency across the included studies, lack of precision of effect estimates, or potential publication bias. </p> </section> </section> <section id="CD007720-sec-0071"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We conducted subgroup analyses a priori for adults and children. We used the Chi² test to test for subgroup interactions in Review Manager 5 software (<a href="./references#CD007720-bbs2-0064" title="Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">Review Manager 2014</a>). We expected further heterogeneity in the effect estimates for mortality and clinical failure by the following factors and conducted subgroup analysis when data provided in the primary studies allowed. When outcome data were not provided by the studies for the specific subgroup, we conducted meta‐regression. </p> <p> <ul id="CD007720-list-0007"> <li> <p>Pneumonia and sepsis severity: analysed by a trial‐level or participant‐level subgroup analysis of severe versus non‐severe pneumonia. Severe pneumonia was assessed using the Pneumonia Severity Index (PSI) and defined as ≥ 4 or equivalent. We regarded trials that did not subgroup participants according to pneumonia severity as including people with severe pneumonia if the mortality rate in the control arm was 9% or more, based on PSI IV mortality rate of 9.3% (<a href="./references#CD007720-bbs2-0041" title="FineMJ , AubleTE , YealyDM , HanusaBH , WeissfeldLA , SingerDE , et al. A prediction rule to identify low‐risk patients with community‐acquired pneumonia. New England Journal of Medicine1997;336(4):243‐50. ">Fine 1997</a>). We also analysed this factor at the study level using meta‐regression of the percentage of participants in the study with hypotension at presentation (systolic blood pressure &lt; 90 mm Hg). </p> </li> <li> <p>Place and mode of acquisition of the infection (CAP + HCAP/HAP/VAP): analysed by subgroup analyses. </p> </li> <li> <p>Underlying chronic obstructive pulmonary disease (COPD): analysed using meta‐regression of the percentage of participants with COPD in the trial. </p> </li> <li> <p>Pathogen causing the pneumonia: analysed through meta‐regression of the percentage of participants with <i>S pneumoniae</i> , <i>Legionella</i> spp, <i>Chlamydophila pneumoniae</i> , and <i>Mycoplasma pneumoniae</i> infections. </p> </li> </ul> </p> <p>We performed meta‐regression using <a href="./references#CD007720-bbs2-0037" title="Biostat. Comprehensive Meta‐Analysis V3.3.07. Version (accessed prior to 30 August 2017). Englewood (NJ): Biostat, 2014. ">Comprehensive Meta‐Analysis V3</a>. </p> </section> <section id="CD007720-sec-0072"> <h4 class="title">Sensitivity analysis</h4> <p>We examined the effect of risk of bias on the results for mortality through sensitivity analysis on allocation concealment, as the most likely factor potentially affecting effect estimates for all‐cause mortality (<a href="./references#CD007720-bbs2-0079" title="WoodL , EggerM , GluudLL , SchulzKF , JüniP , AltmanDG , et al. Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta‐epidemiological study. BMJ2008;336(7644):601‐5. ">Wood 2008</a>). </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD007720-sec-0073" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD007720-sec-0073"></div> <section id="CD007720-sec-0074"> <h3 class="title">Description of studies</h3> <section id="CD007720-sec-0075"> <h4 class="title">Results of the search</h4> <p>The searches yielded 5545 distinct references. We removed 1272 records because they were duplicates. We assessed the titles of 4273 and the abstracts of 88 distinct records. After removing irrelevant and clearly ineligible studies, we assessed the full texts of 24 studies for eligibility. We included 17 studies in the review and meta‐analysis, excluded six studies, and identified one study as awaiting classification because of unclear design and inconsistency in results (<a href="#CD007720-fig-0001">Figure 1</a>). </p> <div class="figure" id="CD007720-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD007720-fig-0001" src="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/image_n/nCD007720-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> </section> <section id="CD007720-sec-0076"> <h4 class="title">Included studies</h4> <p>Details of the included studies are summarised in the <a href="./references#CD007720-sec-0135" title="">Characteristics of included studies</a> table. </p> <p>We included 17 randomised controlled trials in this update, five of which were included in the 2011 review (<a href="./references#CD007720-bbs2-0082" title="ChenY , LiK , PuH , WuT . Corticosteroids for pneumonia. Cochrane Database of Systematic Reviews2011, Issue 3. [DOI: 10.1002/14651858.CD007720.pub2] ">Chen 2011</a>). The studies were performed between 1966 and 2014, but <a href="./references#CD007720-bbs2-0007" title="MarikP , KrausP , SribanteJ , HavlikI , LipmanJ , JohnsonDW . Hydrocortisone and tumour necrosis factor in severe community‐acquired pneumonia. A randomised controlled study. Chest1993;104(2):389‐92. ">Marik 1993</a> did not specify recruitment dates. Six of the studies were multicentre trials including from two to seven centres, all in a single country (<a href="./references#CD007720-bbs2-0001" title="BlumCA , NigroN , BrielM , SchuetzP , UllmerE , Suter‐WidmerI , et al. Adjunct prednisone therapy for patients with community‐acquired pneumonia: a multicentre, double‐blind, randomised, placebo‐controlled trial. Lancet2015;385(9977):1511‐8. ">Blum 2015</a>; <a href="./references#CD007720-bbs2-0002" title="ConfalonieriM , UrbinoR , PotenaA , PiattellaM , ParigiP , PuccioG . Hydrocortisone infusion for severe community‐acquired pneumonia: a preliminary randomised study. American Journal of Respiratory and Critical Care Medicine2005;171(3):242‐8. ">Confalonieri 2005</a>; <a href="./references#CD007720-bbs2-0009" title="MeijvisSC , HardemanH , RemmeltsHH , HeijligenbergR , RijkersGT , vanVelzen‐BladH , et al. Dexamethasone and length of hospital stay in patients with community‐acquired pneumonia: a randomised, double‐blind, placebo‐controlled trial. Lancet2011;377(9782):2023‐30. ">Meijvis 2011</a>; <a href="./references#CD007720-bbs2-0013" title="SabryNA , OmarEE . Corticosteroids and ICU course of community acquired pneumonia in Egyptian settings. Pharmacology &amp; Pharmacy2011;2:73‐81. [DOI: 10.4236/pp.2011.22009] ">Sabry 2011</a>; <a href="./references#CD007720-bbs2-0015" title="TorresA , SibilaO , FerrerM , PolverinoE , MenendezR , MensaJ , et al. Effect of corticosteroids on treatment failure among hospitalized patients with severe community‐acquired pneumonia and high inflammatory response: a randomized clinical trial. JAMA2015;313(7):677‐86. ">Torres 2015</a>; <a href="./references#CD007720-bbs2-0016" title="VanWoenselJB , vanAalderenWM , deWeerdW , JansenNJ . Dexamethasone for treatment of patients mechanically ventilated for lower respiratory tract infection caused by respiratory syncytial virus. Thorax2003;58(5):383‐7. ">Van Woensel 2003</a>), and 11 studies were single‐centre trials. The trials were conducted worldwide: eight in Europe, four in China or Japan, three in the Middle East, and one each in South Africa and Australia. </p> <p>All included trials limited inclusion to participants with CAP, with or without HCAP, who were treated as inpatients. None of the trials included people with CAP who were treated in the community, HAP, or VAP. Inclusion was not limited by CAP pathogens in all adult trials. <a href="./references#CD007720-bbs2-0016" title="VanWoenselJB , vanAalderenWM , deWeerdW , JansenNJ . Dexamethasone for treatment of patients mechanically ventilated for lower respiratory tract infection caused by respiratory syncytial virus. Thorax2003;58(5):383‐7. ">Van Woensel 2003</a> included only young children who were mechanically ventilated due to respiratory syncytial virus lower respiratory tract infections (82 infants, of whom 41 had pneumonia). Two trials limited inclusion to children with <i>M pneumoniae</i> (<a href="./references#CD007720-bbs2-0006" title="LuoZ , LuoJ , LiuE , XuX , LiuY , ZengF , et al. Effects of prednisolone on refractory Mycoplasma pneumoniae pneumonia in children. Pediatric Pulmonology2014;49(4):377‐80. ">Luo 2014</a>; <a href="./references#CD007720-bbs2-0017" title="WuYJ , SunJ , ZhangJH , FengLL . Clinical efficacy of adjuvant therapy with glucocorticoids in children with lobar pneumonia caused by Mycoplasma pneumoniae . Zhongguo Dang Dai Er Ke Za Zhi [Chinese Journal of Contemporary Pediatrics]2014;16(4):401‐5. ">Wu 2014</a>). </p> <p>A total of 2264 participants were randomised (1122 to the intervention arm), of whom 1954 (86%) were adults (n = 13 trials, mean age 69.8 years) and 307 (14%) were children (n = 4 trials, mean age 5.6 years, <a href="./references#CD007720-bbs2-0006" title="LuoZ , LuoJ , LiuE , XuX , LiuY , ZengF , et al. Effects of prednisolone on refractory Mycoplasma pneumoniae pneumonia in children. Pediatric Pulmonology2014;49(4):377‐80. ">Luo 2014</a>; <a href="./references#CD007720-bbs2-0012" title="NagyB , GasparI , PappA , BeneZ , NagyBJr , VokoZ , et al. Efficacy of methylprednisolone in children with severe community acquired pneumonia. Pediatric Pulmonology2013;48(2):168‐75. ">Nagy 2013</a>; <a href="./references#CD007720-bbs2-0016" title="VanWoenselJB , vanAalderenWM , deWeerdW , JansenNJ . Dexamethasone for treatment of patients mechanically ventilated for lower respiratory tract infection caused by respiratory syncytial virus. Thorax2003;58(5):383‐7. ">Van Woensel 2003</a>; <a href="./references#CD007720-bbs2-0017" title="WuYJ , SunJ , ZhangJH , FengLL . Clinical efficacy of adjuvant therapy with glucocorticoids in children with lobar pneumonia caused by Mycoplasma pneumoniae . Zhongguo Dang Dai Er Ke Za Zhi [Chinese Journal of Contemporary Pediatrics]2014;16(4):401‐5. ">Wu 2014</a>). Of the adult trials, three reported that no people with chronic lung disease were included (<a href="./references#CD007720-bbs2-0010" title="MikamiK , SuzukiM , KitagawaH , KawakamiM , HirotaN , YamaguchiH . Efficacy of corticosteroids in the treatment of community‐acquired pneumonia requiring hospitalisation. Lung2007;185(5):249‐55. ">Mikami 2007</a>; <a href="./references#CD007720-bbs2-0011" title="NafaeRM , RagabMI , AmanyFM , RashedSB . Adjuvant role of corticosteroids in the treatment of community‐acquired pneumonia. Egyptian Journal of Chest Diseases and Tuberculosis2013;62(3):439–45. ">Nafae 2013</a>; <a href="./references#CD007720-bbs2-0013" title="SabryNA , OmarEE . Corticosteroids and ICU course of community acquired pneumonia in Egyptian settings. Pharmacology &amp; Pharmacy2011;2:73‐81. [DOI: 10.4236/pp.2011.22009] ">Sabry 2011</a>); in six trials reporting data between 11.2% and 35.9% of participants had chronic lung disease. A single trial reported that people with diabetes mellitus were not included (<a href="./references#CD007720-bbs2-0008" title="McHardyVU , SchonellME . Ampicillin dosage and use of prednisolone in treatment of pneumonia: co‐operative controlled trial. British Medical Journal1972;4(5840):569‐73. ">McHardy 1972</a>), and in five trials between 10.3% and 19.7% of participants had diabetes<i>.</i> </p> <p>Six trials included only adults with severe pneumonia. Four trials defined severe pneumonia according to the Infectious Diseases Society of America and American Thoracic Society guidelines (ATS/IDSA guidelines) for severe pneumonia, <a href="./references#CD007720-bbs2-0054" title="MandellLA , WunderinkRG , AnzuetoA , BartlettJG , CampbellGD , DeanNC , et al. Infectious Diseases Society of America. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community‐acquired pneumonia in adults. Clinical Infectious Diseases2007;44(Suppl 2):S27‐72. ">Mandell 2007</a>, or earlier versions of these guidelines (<a href="./references#CD007720-bbs2-0002" title="ConfalonieriM , UrbinoR , PotenaA , PiattellaM , ParigiP , PuccioG . Hydrocortisone infusion for severe community‐acquired pneumonia: a preliminary randomised study. American Journal of Respiratory and Critical Care Medicine2005;171(3):242‐8. ">Confalonieri 2005</a>; <a href="./references#CD007720-bbs2-0003" title="El‐GhamrawyAH , ShokierMH , EsmatAA . Effects of low‐dose hydrocortisone in ICU patients with severe community‐acquired pneumonia. Egyptian Journal of Chest Diseases and Tuberculosis2006;55:91‐9. ">El‐Ghamrawy 2006</a>; <a href="./references#CD007720-bbs2-0013" title="SabryNA , OmarEE . Corticosteroids and ICU course of community acquired pneumonia in Egyptian settings. Pharmacology &amp; Pharmacy2011;2:73‐81. [DOI: 10.4236/pp.2011.22009] ">Sabry 2011</a>; <a href="./references#CD007720-bbs2-0015" title="TorresA , SibilaO , FerrerM , PolverinoE , MenendezR , MensaJ , et al. Effect of corticosteroids on treatment failure among hospitalized patients with severe community‐acquired pneumonia and high inflammatory response: a randomized clinical trial. JAMA2015;313(7):677‐86. ">Torres 2015</a>). <a href="./references#CD007720-bbs2-0007" title="MarikP , KrausP , SribanteJ , HavlikI , LipmanJ , JohnsonDW . Hydrocortisone and tumour necrosis factor in severe community‐acquired pneumonia. A randomised controlled study. Chest1993;104(2):389‐92. ">Marik 1993</a> defined severe pneumonia as presentation of three or more British Thoracic Society (BTS) criteria for severe pneumonia (<a href="./references#CD007720-bbs2-0034" title="British Thoracic Society. Community‐acquired pneumonia in adults in British hospitals in 1982‐1983: a survey of aetiology, mortality, prognostic factors and outcome. The British Thoracic Society and the Public Health Laboratory Service. Quarterly Journal of Medicine1987;62(239):195‐220. ">BTS guidelines 1987</a>). <a href="./references#CD007720-bbs2-0004" title="Fernández‐SerranoS , DorcaJ , Garcia‐VidalC , Fernández‐SabéN , CarratalàJ , Fernández‐AgüeraA , et al. Effect of corticosteroids on the clinical course of community‐acquired pneumonia: a randomized controlled trial. Critical Care2011;15(2):R96. ">Fernández‐Serrano 2011</a> defined pneumonia as the presence of respiratory failure and extensive radiologically confirmed consolidations. </p> <p>The intervention included oral prednisone in three trials (<a href="./references#CD007720-bbs2-0001" title="BlumCA , NigroN , BrielM , SchuetzP , UllmerE , Suter‐WidmerI , et al. Adjunct prednisone therapy for patients with community‐acquired pneumonia: a multicentre, double‐blind, randomised, placebo‐controlled trial. Lancet2015;385(9977):1511‐8. ">Blum 2015</a>; <a href="./references#CD007720-bbs2-0006" title="LuoZ , LuoJ , LiuE , XuX , LiuY , ZengF , et al. Effects of prednisolone on refractory Mycoplasma pneumoniae pneumonia in children. Pediatric Pulmonology2014;49(4):377‐80. ">Luo 2014</a>; <a href="./references#CD007720-bbs2-0008" title="McHardyVU , SchonellME . Ampicillin dosage and use of prednisolone in treatment of pneumonia: co‐operative controlled trial. British Medical Journal1972;4(5840):569‐73. ">McHardy 1972</a>), and intravenous dexamethasone, hydrocortisone, or methylprednisolone in 13 trials. One trial used prednisone without limiting the administration route (<a href="./references#CD007720-bbs2-0014" title="SnijdersD , DanielsJM , deGraaffCS , van derWerfTS , BoersmaWG . Efficacy of corticosteroids in community‐acquired pneumonia: a randomized double‐blinded clinical trial. American Journal of Respiratory and Critical Care Medicine2010;181(9):975‐82. ">Snijders 2010</a>). The duration of corticosteroid treatment was 10 days in one trial (<a href="./references#CD007720-bbs2-0004" title="Fernández‐SerranoS , DorcaJ , Garcia‐VidalC , Fernández‐SabéN , CarratalàJ , Fernández‐AgüeraA , et al. Effect of corticosteroids on the clinical course of community‐acquired pneumonia: a randomized controlled trial. Critical Care2011;15(2):R96. ">Fernández‐Serrano 2011</a>), seven to 10 days in one trial (<a href="./references#CD007720-bbs2-0017" title="WuYJ , SunJ , ZhangJH , FengLL . Clinical efficacy of adjuvant therapy with glucocorticoids in children with lobar pneumonia caused by Mycoplasma pneumoniae . Zhongguo Dang Dai Er Ke Za Zhi [Chinese Journal of Contemporary Pediatrics]2014;16(4):401‐5. ">Wu 2014</a>), seven days in seven trials (<a href="./references#CD007720-bbs2-0001" title="BlumCA , NigroN , BrielM , SchuetzP , UllmerE , Suter‐WidmerI , et al. Adjunct prednisone therapy for patients with community‐acquired pneumonia: a multicentre, double‐blind, randomised, placebo‐controlled trial. Lancet2015;385(9977):1511‐8. ">Blum 2015</a>; <a href="./references#CD007720-bbs2-0002" title="ConfalonieriM , UrbinoR , PotenaA , PiattellaM , ParigiP , PuccioG . Hydrocortisone infusion for severe community‐acquired pneumonia: a preliminary randomised study. American Journal of Respiratory and Critical Care Medicine2005;171(3):242‐8. ">Confalonieri 2005</a>; <a href="./references#CD007720-bbs2-0003" title="El‐GhamrawyAH , ShokierMH , EsmatAA . Effects of low‐dose hydrocortisone in ICU patients with severe community‐acquired pneumonia. Egyptian Journal of Chest Diseases and Tuberculosis2006;55:91‐9. ">El‐Ghamrawy 2006</a>; <a href="./references#CD007720-bbs2-0008" title="McHardyVU , SchonellME . Ampicillin dosage and use of prednisolone in treatment of pneumonia: co‐operative controlled trial. British Medical Journal1972;4(5840):569‐73. ">McHardy 1972</a>; <a href="./references#CD007720-bbs2-0011" title="NafaeRM , RagabMI , AmanyFM , RashedSB . Adjuvant role of corticosteroids in the treatment of community‐acquired pneumonia. Egyptian Journal of Chest Diseases and Tuberculosis2013;62(3):439–45. ">Nafae 2013</a>; <a href="./references#CD007720-bbs2-0013" title="SabryNA , OmarEE . Corticosteroids and ICU course of community acquired pneumonia in Egyptian settings. Pharmacology &amp; Pharmacy2011;2:73‐81. [DOI: 10.4236/pp.2011.22009] ">Sabry 2011</a>; <a href="./references#CD007720-bbs2-0014" title="SnijdersD , DanielsJM , deGraaffCS , van derWerfTS , BoersmaWG . Efficacy of corticosteroids in community‐acquired pneumonia: a randomized double‐blinded clinical trial. American Journal of Respiratory and Critical Care Medicine2010;181(9):975‐82. ">Snijders 2010</a>), five days in three trials (<a href="./references#CD007720-bbs2-0006" title="LuoZ , LuoJ , LiuE , XuX , LiuY , ZengF , et al. Effects of prednisolone on refractory Mycoplasma pneumoniae pneumonia in children. Pediatric Pulmonology2014;49(4):377‐80. ">Luo 2014</a>; <a href="./references#CD007720-bbs2-0012" title="NagyB , GasparI , PappA , BeneZ , NagyBJr , VokoZ , et al. Efficacy of methylprednisolone in children with severe community acquired pneumonia. Pediatric Pulmonology2013;48(2):168‐75. ">Nagy 2013</a>; <a href="./references#CD007720-bbs2-0015" title="TorresA , SibilaO , FerrerM , PolverinoE , MenendezR , MensaJ , et al. Effect of corticosteroids on treatment failure among hospitalized patients with severe community‐acquired pneumonia and high inflammatory response: a randomized clinical trial. JAMA2015;313(7):677‐86. ">Torres 2015</a>), and two to four days in four trials (<a href="./references#CD007720-bbs2-0005" title="HatakeyamaS , TachibanaA , SuzukiK , OkanoH . Treatment of aspiration pneumonia with low‐dose methylprednisolone and antibiotics. Japanese Journal of Thoracic Diseases1998;33(1):51‐6. ">Hatakeyama 1995</a>; <a href="./references#CD007720-bbs2-0009" title="MeijvisSC , HardemanH , RemmeltsHH , HeijligenbergR , RijkersGT , vanVelzen‐BladH , et al. Dexamethasone and length of hospital stay in patients with community‐acquired pneumonia: a randomised, double‐blind, placebo‐controlled trial. Lancet2011;377(9782):2023‐30. ">Meijvis 2011</a>; <a href="./references#CD007720-bbs2-0010" title="MikamiK , SuzukiM , KitagawaH , KawakamiM , HirotaN , YamaguchiH . Efficacy of corticosteroids in the treatment of community‐acquired pneumonia requiring hospitalisation. Lung2007;185(5):249‐55. ">Mikami 2007</a>; <a href="./references#CD007720-bbs2-0016" title="VanWoenselJB , vanAalderenWM , deWeerdW , JansenNJ . Dexamethasone for treatment of patients mechanically ventilated for lower respiratory tract infection caused by respiratory syncytial virus. Thorax2003;58(5):383‐7. ">Van Woensel 2003</a>). In one trial only one dose of corticosteroids was given (<a href="./references#CD007720-bbs2-0007" title="MarikP , KrausP , SribanteJ , HavlikI , LipmanJ , JohnsonDW . Hydrocortisone and tumour necrosis factor in severe community‐acquired pneumonia. A randomised controlled study. Chest1993;104(2):389‐92. ">Marik 1993</a>). Most adult trials used steroid doses equivalent to 40 mg to 50 mg of prednisone per day. The comparator for corticosteroids was placebo in 11 trials and no treatment in six trials (<a href="./references#CD007720-bbs2-0002" title="ConfalonieriM , UrbinoR , PotenaA , PiattellaM , ParigiP , PuccioG . Hydrocortisone infusion for severe community‐acquired pneumonia: a preliminary randomised study. American Journal of Respiratory and Critical Care Medicine2005;171(3):242‐8. ">Confalonieri 2005</a>; <a href="./references#CD007720-bbs2-0006" title="LuoZ , LuoJ , LiuE , XuX , LiuY , ZengF , et al. Effects of prednisolone on refractory Mycoplasma pneumoniae pneumonia in children. Pediatric Pulmonology2014;49(4):377‐80. ">Luo 2014</a>; <a href="./references#CD007720-bbs2-0008" title="McHardyVU , SchonellME . Ampicillin dosage and use of prednisolone in treatment of pneumonia: co‐operative controlled trial. British Medical Journal1972;4(5840):569‐73. ">McHardy 1972</a>; <a href="./references#CD007720-bbs2-0010" title="MikamiK , SuzukiM , KitagawaH , KawakamiM , HirotaN , YamaguchiH . Efficacy of corticosteroids in the treatment of community‐acquired pneumonia requiring hospitalisation. Lung2007;185(5):249‐55. ">Mikami 2007</a>; <a href="./references#CD007720-bbs2-0013" title="SabryNA , OmarEE . Corticosteroids and ICU course of community acquired pneumonia in Egyptian settings. Pharmacology &amp; Pharmacy2011;2:73‐81. [DOI: 10.4236/pp.2011.22009] ">Sabry 2011</a>; <a href="./references#CD007720-bbs2-0017" title="WuYJ , SunJ , ZhangJH , FengLL . Clinical efficacy of adjuvant therapy with glucocorticoids in children with lobar pneumonia caused by Mycoplasma pneumoniae . Zhongguo Dang Dai Er Ke Za Zhi [Chinese Journal of Contemporary Pediatrics]2014;16(4):401‐5. ">Wu 2014</a>). </p> <p>Seven trials were funded by academic sponsors (<a href="./references#CD007720-bbs2-0001" title="BlumCA , NigroN , BrielM , SchuetzP , UllmerE , Suter‐WidmerI , et al. Adjunct prednisone therapy for patients with community‐acquired pneumonia: a multicentre, double‐blind, randomised, placebo‐controlled trial. Lancet2015;385(9977):1511‐8. ">Blum 2015</a>; <a href="./references#CD007720-bbs2-0002" title="ConfalonieriM , UrbinoR , PotenaA , PiattellaM , ParigiP , PuccioG . Hydrocortisone infusion for severe community‐acquired pneumonia: a preliminary randomised study. American Journal of Respiratory and Critical Care Medicine2005;171(3):242‐8. ">Confalonieri 2005</a>; <a href="./references#CD007720-bbs2-0004" title="Fernández‐SerranoS , DorcaJ , Garcia‐VidalC , Fernández‐SabéN , CarratalàJ , Fernández‐AgüeraA , et al. Effect of corticosteroids on the clinical course of community‐acquired pneumonia: a randomized controlled trial. Critical Care2011;15(2):R96. ">Fernández‐Serrano 2011</a>; <a href="./references#CD007720-bbs2-0009" title="MeijvisSC , HardemanH , RemmeltsHH , HeijligenbergR , RijkersGT , vanVelzen‐BladH , et al. Dexamethasone and length of hospital stay in patients with community‐acquired pneumonia: a randomised, double‐blind, placebo‐controlled trial. Lancet2011;377(9782):2023‐30. ">Meijvis 2011</a>; <a href="./references#CD007720-bbs2-0012" title="NagyB , GasparI , PappA , BeneZ , NagyBJr , VokoZ , et al. Efficacy of methylprednisolone in children with severe community acquired pneumonia. Pediatric Pulmonology2013;48(2):168‐75. ">Nagy 2013</a>; <a href="./references#CD007720-bbs2-0015" title="TorresA , SibilaO , FerrerM , PolverinoE , MenendezR , MensaJ , et al. Effect of corticosteroids on treatment failure among hospitalized patients with severe community‐acquired pneumonia and high inflammatory response: a randomized clinical trial. JAMA2015;313(7):677‐86. ">Torres 2015</a>; <a href="./references#CD007720-bbs2-0016" title="VanWoenselJB , vanAalderenWM , deWeerdW , JansenNJ . Dexamethasone for treatment of patients mechanically ventilated for lower respiratory tract infection caused by respiratory syncytial virus. Thorax2003;58(5):383‐7. ">Van Woensel 2003</a>), one trial was funded by a pharmaceutical company (<a href="./references#CD007720-bbs2-0014" title="SnijdersD , DanielsJM , deGraaffCS , van derWerfTS , BoersmaWG . Efficacy of corticosteroids in community‐acquired pneumonia: a randomized double‐blinded clinical trial. American Journal of Respiratory and Critical Care Medicine2010;181(9):975‐82. ">Snijders 2010</a>), and one trial reported receiving no funding (<a href="./references#CD007720-bbs2-0013" title="SabryNA , OmarEE . Corticosteroids and ICU course of community acquired pneumonia in Egyptian settings. Pharmacology &amp; Pharmacy2011;2:73‐81. [DOI: 10.4236/pp.2011.22009] ">Sabry 2011</a>). The remaining eight trials did not report their funding source. We sought additional data for all trials, which two authors supplied (<a href="./references#CD007720-bbs2-0001" title="BlumCA , NigroN , BrielM , SchuetzP , UllmerE , Suter‐WidmerI , et al. Adjunct prednisone therapy for patients with community‐acquired pneumonia: a multicentre, double‐blind, randomised, placebo‐controlled trial. Lancet2015;385(9977):1511‐8. ">Blum 2015</a>; <a href="./references#CD007720-bbs2-0015" title="TorresA , SibilaO , FerrerM , PolverinoE , MenendezR , MensaJ , et al. Effect of corticosteroids on treatment failure among hospitalized patients with severe community‐acquired pneumonia and high inflammatory response: a randomized clinical trial. JAMA2015;313(7):677‐86. ">Torres 2015</a>). </p> </section> <section id="CD007720-sec-0077"> <h4 class="title">Excluded studies</h4> <p>We excluded six studies (see <a href="./references#CD007720-sec-0136" title="">Characteristics of excluded studies</a> table). One trial that was included in the 2011 review was excluded because it examined the use of inhaled corticosteroids (<a href="./references#CD007720-bbs2-0018" title="CaoLF , LuYM , MaHG , MaM . Budesonide inhaling auxiliary therapy after Mycoplasma pneumoniae infection of children. International Journal of Respiration2007;27(8):567‐9. ">Cao 2007</a>). Other reasons for exclusion were: not limited to people with pneumonia (<a href="./references#CD007720-bbs2-0022" title="VanWoenselJB , VyasH , STAR Trial Group. Dexamethasone in children mechanically ventilated for lower respiratory tract infection caused by respiratory syncytial virus: a randomized controlled trial. Critical Care Medicine2011;39(7):1779‐83. ">Van Woensel 2011</a>), corticosteroids given to both treatment arms (<a href="./references#CD007720-bbs2-0019" title="HuangL , GaoX , ChenM . Early treatment with corticosteroids in patients with Mycoplasma pneumoniae pneumonia: a randomized clinical trial. Journal of Tropical Pediatrics2014;60(5):338‐42. ">Huang 2014</a>), participants in the control group were subsequently given either corticosteroids or intravenous immunoglobulin therapy (<a href="./references#CD007720-bbs2-0021" title="ShanLS , LiuX , KangXY , WangF , HanXH , ShangYX . Effects of methylprednisolone or immunoglobulin when added to standard treatment with intravenous azithromycin for refractory Mycoplasma pneumoniae pneumonia in children. World Journal of Pediatrics 2017 Jan 27 [Epub ahead of print]. [DOI: 10.1007/s12519‐017‐0014‐9] ">Shan 2017</a>), quasi‐randomisation (<a href="./references#CD007720-bbs2-0023" title="WagnerHNJr , BennettILJr , LasagnaL , CluffLE , RosenthalMB , MirickGS . The effect of hydrocortisone upon the course of pneumococcal pneumonia treated with penicillin. Bulletin of the Johns Hopkins Hospital1956;98(3):197‐215. ">Wagner 1956</a>), and one non‐randomised trial (<a href="./references#CD007720-bbs2-0020" title="MontónC , EwigS , TorresA , El‐EbiaryM , FilellaX , RañóA , et al. Role of glucocorticoids on inflammatory response in nonimmunosuppressed patients with pneumonia: a pilot study. European Respiratory Journal1999;14(1):218‐20. ">Montón 1999</a>). </p> <section id="CD007720-sec-0078"> <h5 class="title">Studies awaiting classification</h5> <p>One trial that assessed children with refractory <i>M pneumoniae</i> pneumonia is awaiting classification (<a href="./references#CD007720-bbs2-0024" title="LanY , YangD , ChenZ , TangL , XuY , ChengY . Effectiveness of methylprednisolone in treatment of children with refractory Mycoplasma pneumoniae pneumonia and its relationship with bronchoalveolar lavage cytokine levels. Zhonghua Er Ke Za Zhi2015;53(10):779‐83. ">Lan 2015</a>). We contacted the authors for clarification about study design and inconsistencies in reported results. </p> </section> </section> </section> <section id="CD007720-sec-0079"> <h3 class="title">Risk of bias in included studies</h3> <p>Risk of bias for all trials is summarised in <a href="#CD007720-fig-0002">Figure 2</a> and <a href="#CD007720-fig-0003">Figure 3</a>. </p> <div class="figure" id="CD007720-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD007720-fig-0002" src="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/image_n/nCD007720-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD007720-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD007720-fig-0003" src="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/image_n/nCD007720-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <section id="CD007720-sec-0080"> <h4 class="title">Allocation</h4> <p>We assessed generation of the randomisation sequencing as low risk of bias in eight trials (<a href="./references#CD007720-bbs2-0001" title="BlumCA , NigroN , BrielM , SchuetzP , UllmerE , Suter‐WidmerI , et al. Adjunct prednisone therapy for patients with community‐acquired pneumonia: a multicentre, double‐blind, randomised, placebo‐controlled trial. Lancet2015;385(9977):1511‐8. ">Blum 2015</a>; <a href="./references#CD007720-bbs2-0002" title="ConfalonieriM , UrbinoR , PotenaA , PiattellaM , ParigiP , PuccioG . Hydrocortisone infusion for severe community‐acquired pneumonia: a preliminary randomised study. American Journal of Respiratory and Critical Care Medicine2005;171(3):242‐8. ">Confalonieri 2005</a>; <a href="./references#CD007720-bbs2-0007" title="MarikP , KrausP , SribanteJ , HavlikI , LipmanJ , JohnsonDW . Hydrocortisone and tumour necrosis factor in severe community‐acquired pneumonia. A randomised controlled study. Chest1993;104(2):389‐92. ">Marik 1993</a>; <a href="./references#CD007720-bbs2-0009" title="MeijvisSC , HardemanH , RemmeltsHH , HeijligenbergR , RijkersGT , vanVelzen‐BladH , et al. Dexamethasone and length of hospital stay in patients with community‐acquired pneumonia: a randomised, double‐blind, placebo‐controlled trial. Lancet2011;377(9782):2023‐30. ">Meijvis 2011</a>; <a href="./references#CD007720-bbs2-0012" title="NagyB , GasparI , PappA , BeneZ , NagyBJr , VokoZ , et al. Efficacy of methylprednisolone in children with severe community acquired pneumonia. Pediatric Pulmonology2013;48(2):168‐75. ">Nagy 2013</a>; <a href="./references#CD007720-bbs2-0014" title="SnijdersD , DanielsJM , deGraaffCS , van derWerfTS , BoersmaWG . Efficacy of corticosteroids in community‐acquired pneumonia: a randomized double‐blinded clinical trial. American Journal of Respiratory and Critical Care Medicine2010;181(9):975‐82. ">Snijders 2010</a>; <a href="./references#CD007720-bbs2-0015" title="TorresA , SibilaO , FerrerM , PolverinoE , MenendezR , MensaJ , et al. Effect of corticosteroids on treatment failure among hospitalized patients with severe community‐acquired pneumonia and high inflammatory response: a randomized clinical trial. JAMA2015;313(7):677‐86. ">Torres 2015</a>; <a href="./references#CD007720-bbs2-0016" title="VanWoenselJB , vanAalderenWM , deWeerdW , JansenNJ . Dexamethasone for treatment of patients mechanically ventilated for lower respiratory tract infection caused by respiratory syncytial virus. Thorax2003;58(5):383‐7. ">Van Woensel 2003</a>). The risk of bias was unclear in nine trials. We assessed the risk of bias for allocation concealment as low in eight trials (<a href="./references#CD007720-bbs2-0001" title="BlumCA , NigroN , BrielM , SchuetzP , UllmerE , Suter‐WidmerI , et al. Adjunct prednisone therapy for patients with community‐acquired pneumonia: a multicentre, double‐blind, randomised, placebo‐controlled trial. Lancet2015;385(9977):1511‐8. ">Blum 2015</a>; <a href="./references#CD007720-bbs2-0002" title="ConfalonieriM , UrbinoR , PotenaA , PiattellaM , ParigiP , PuccioG . Hydrocortisone infusion for severe community‐acquired pneumonia: a preliminary randomised study. American Journal of Respiratory and Critical Care Medicine2005;171(3):242‐8. ">Confalonieri 2005</a>; <a href="./references#CD007720-bbs2-0005" title="HatakeyamaS , TachibanaA , SuzukiK , OkanoH . Treatment of aspiration pneumonia with low‐dose methylprednisolone and antibiotics. Japanese Journal of Thoracic Diseases1998;33(1):51‐6. ">Hatakeyama 1995</a>; <a href="./references#CD007720-bbs2-0008" title="McHardyVU , SchonellME . Ampicillin dosage and use of prednisolone in treatment of pneumonia: co‐operative controlled trial. British Medical Journal1972;4(5840):569‐73. ">McHardy 1972</a>; <a href="./references#CD007720-bbs2-0009" title="MeijvisSC , HardemanH , RemmeltsHH , HeijligenbergR , RijkersGT , vanVelzen‐BladH , et al. Dexamethasone and length of hospital stay in patients with community‐acquired pneumonia: a randomised, double‐blind, placebo‐controlled trial. Lancet2011;377(9782):2023‐30. ">Meijvis 2011</a>; <a href="./references#CD007720-bbs2-0014" title="SnijdersD , DanielsJM , deGraaffCS , van derWerfTS , BoersmaWG . Efficacy of corticosteroids in community‐acquired pneumonia: a randomized double‐blinded clinical trial. American Journal of Respiratory and Critical Care Medicine2010;181(9):975‐82. ">Snijders 2010</a>; <a href="./references#CD007720-bbs2-0015" title="TorresA , SibilaO , FerrerM , PolverinoE , MenendezR , MensaJ , et al. Effect of corticosteroids on treatment failure among hospitalized patients with severe community‐acquired pneumonia and high inflammatory response: a randomized clinical trial. JAMA2015;313(7):677‐86. ">Torres 2015</a>; <a href="./references#CD007720-bbs2-0016" title="VanWoenselJB , vanAalderenWM , deWeerdW , JansenNJ . Dexamethasone for treatment of patients mechanically ventilated for lower respiratory tract infection caused by respiratory syncytial virus. Thorax2003;58(5):383‐7. ">Van Woensel 2003</a>), and unclear in nine trials. </p> </section> <section id="CD007720-sec-0081"> <h4 class="title">Blinding</h4> <p>We assessed nine double‐blinded, placebo‐controlled trials as at low risk of bias (<a href="./references#CD007720-bbs2-0001" title="BlumCA , NigroN , BrielM , SchuetzP , UllmerE , Suter‐WidmerI , et al. Adjunct prednisone therapy for patients with community‐acquired pneumonia: a multicentre, double‐blind, randomised, placebo‐controlled trial. Lancet2015;385(9977):1511‐8. ">Blum 2015</a>; <a href="./references#CD007720-bbs2-0002" title="ConfalonieriM , UrbinoR , PotenaA , PiattellaM , ParigiP , PuccioG . Hydrocortisone infusion for severe community‐acquired pneumonia: a preliminary randomised study. American Journal of Respiratory and Critical Care Medicine2005;171(3):242‐8. ">Confalonieri 2005</a>; <a href="./references#CD007720-bbs2-0004" title="Fernández‐SerranoS , DorcaJ , Garcia‐VidalC , Fernández‐SabéN , CarratalàJ , Fernández‐AgüeraA , et al. Effect of corticosteroids on the clinical course of community‐acquired pneumonia: a randomized controlled trial. Critical Care2011;15(2):R96. ">Fernández‐Serrano 2011</a>; <a href="./references#CD007720-bbs2-0005" title="HatakeyamaS , TachibanaA , SuzukiK , OkanoH . Treatment of aspiration pneumonia with low‐dose methylprednisolone and antibiotics. Japanese Journal of Thoracic Diseases1998;33(1):51‐6. ">Hatakeyama 1995</a>; <a href="./references#CD007720-bbs2-0009" title="MeijvisSC , HardemanH , RemmeltsHH , HeijligenbergR , RijkersGT , vanVelzen‐BladH , et al. Dexamethasone and length of hospital stay in patients with community‐acquired pneumonia: a randomised, double‐blind, placebo‐controlled trial. Lancet2011;377(9782):2023‐30. ">Meijvis 2011</a>; <a href="./references#CD007720-bbs2-0013" title="SabryNA , OmarEE . Corticosteroids and ICU course of community acquired pneumonia in Egyptian settings. Pharmacology &amp; Pharmacy2011;2:73‐81. [DOI: 10.4236/pp.2011.22009] ">Sabry 2011</a>; <a href="./references#CD007720-bbs2-0014" title="SnijdersD , DanielsJM , deGraaffCS , van derWerfTS , BoersmaWG . Efficacy of corticosteroids in community‐acquired pneumonia: a randomized double‐blinded clinical trial. American Journal of Respiratory and Critical Care Medicine2010;181(9):975‐82. ">Snijders 2010</a>; <a href="./references#CD007720-bbs2-0015" title="TorresA , SibilaO , FerrerM , PolverinoE , MenendezR , MensaJ , et al. Effect of corticosteroids on treatment failure among hospitalized patients with severe community‐acquired pneumonia and high inflammatory response: a randomized clinical trial. JAMA2015;313(7):677‐86. ">Torres 2015</a>; <a href="./references#CD007720-bbs2-0016" title="VanWoenselJB , vanAalderenWM , deWeerdW , JansenNJ . Dexamethasone for treatment of patients mechanically ventilated for lower respiratory tract infection caused by respiratory syncytial virus. Thorax2003;58(5):383‐7. ">Van Woensel 2003</a>). We assessed seven open‐label trials as at high risk of bias (<a href="./references#CD007720-bbs2-0006" title="LuoZ , LuoJ , LiuE , XuX , LiuY , ZengF , et al. Effects of prednisolone on refractory Mycoplasma pneumoniae pneumonia in children. Pediatric Pulmonology2014;49(4):377‐80. ">Luo 2014</a>; <a href="./references#CD007720-bbs2-0007" title="MarikP , KrausP , SribanteJ , HavlikI , LipmanJ , JohnsonDW . Hydrocortisone and tumour necrosis factor in severe community‐acquired pneumonia. A randomised controlled study. Chest1993;104(2):389‐92. ">Marik 1993</a>; <a href="./references#CD007720-bbs2-0008" title="McHardyVU , SchonellME . Ampicillin dosage and use of prednisolone in treatment of pneumonia: co‐operative controlled trial. British Medical Journal1972;4(5840):569‐73. ">McHardy 1972</a>; <a href="./references#CD007720-bbs2-0010" title="MikamiK , SuzukiM , KitagawaH , KawakamiM , HirotaN , YamaguchiH . Efficacy of corticosteroids in the treatment of community‐acquired pneumonia requiring hospitalisation. Lung2007;185(5):249‐55. ">Mikami 2007</a>; <a href="./references#CD007720-bbs2-0011" title="NafaeRM , RagabMI , AmanyFM , RashedSB . Adjuvant role of corticosteroids in the treatment of community‐acquired pneumonia. Egyptian Journal of Chest Diseases and Tuberculosis2013;62(3):439–45. ">Nafae 2013</a>; <a href="./references#CD007720-bbs2-0012" title="NagyB , GasparI , PappA , BeneZ , NagyBJr , VokoZ , et al. Efficacy of methylprednisolone in children with severe community acquired pneumonia. Pediatric Pulmonology2013;48(2):168‐75. ">Nagy 2013</a>; <a href="./references#CD007720-bbs2-0017" title="WuYJ , SunJ , ZhangJH , FengLL . Clinical efficacy of adjuvant therapy with glucocorticoids in children with lobar pneumonia caused by Mycoplasma pneumoniae . Zhongguo Dang Dai Er Ke Za Zhi [Chinese Journal of Contemporary Pediatrics]2014;16(4):401‐5. ">Wu 2014</a>). <a href="./references#CD007720-bbs2-0003" title="El‐GhamrawyAH , ShokierMH , EsmatAA . Effects of low‐dose hydrocortisone in ICU patients with severe community‐acquired pneumonia. Egyptian Journal of Chest Diseases and Tuberculosis2006;55:91‐9. ">El‐Ghamrawy 2006</a> used a placebo, but did not describe blinding and was therefore assessed as at unclear risk of bias. We assessed four trials in which outcome assessors were blinded as at low risk of bias (<a href="./references#CD007720-bbs2-0001" title="BlumCA , NigroN , BrielM , SchuetzP , UllmerE , Suter‐WidmerI , et al. Adjunct prednisone therapy for patients with community‐acquired pneumonia: a multicentre, double‐blind, randomised, placebo‐controlled trial. Lancet2015;385(9977):1511‐8. ">Blum 2015</a>; <a href="./references#CD007720-bbs2-0002" title="ConfalonieriM , UrbinoR , PotenaA , PiattellaM , ParigiP , PuccioG . Hydrocortisone infusion for severe community‐acquired pneumonia: a preliminary randomised study. American Journal of Respiratory and Critical Care Medicine2005;171(3):242‐8. ">Confalonieri 2005</a>; <a href="./references#CD007720-bbs2-0009" title="MeijvisSC , HardemanH , RemmeltsHH , HeijligenbergR , RijkersGT , vanVelzen‐BladH , et al. Dexamethasone and length of hospital stay in patients with community‐acquired pneumonia: a randomised, double‐blind, placebo‐controlled trial. Lancet2011;377(9782):2023‐30. ">Meijvis 2011</a>; <a href="./references#CD007720-bbs2-0015" title="TorresA , SibilaO , FerrerM , PolverinoE , MenendezR , MensaJ , et al. Effect of corticosteroids on treatment failure among hospitalized patients with severe community‐acquired pneumonia and high inflammatory response: a randomized clinical trial. JAMA2015;313(7):677‐86. ">Torres 2015</a>). Nine trials did not specify if outcome assessors were blinded and were assessed as at unclear risk of bias (<a href="./references#CD007720-bbs2-0003" title="El‐GhamrawyAH , ShokierMH , EsmatAA . Effects of low‐dose hydrocortisone in ICU patients with severe community‐acquired pneumonia. Egyptian Journal of Chest Diseases and Tuberculosis2006;55:91‐9. ">El‐Ghamrawy 2006</a>; <a href="./references#CD007720-bbs2-0004" title="Fernández‐SerranoS , DorcaJ , Garcia‐VidalC , Fernández‐SabéN , CarratalàJ , Fernández‐AgüeraA , et al. Effect of corticosteroids on the clinical course of community‐acquired pneumonia: a randomized controlled trial. Critical Care2011;15(2):R96. ">Fernández‐Serrano 2011</a>; <a href="./references#CD007720-bbs2-0005" title="HatakeyamaS , TachibanaA , SuzukiK , OkanoH . Treatment of aspiration pneumonia with low‐dose methylprednisolone and antibiotics. Japanese Journal of Thoracic Diseases1998;33(1):51‐6. ">Hatakeyama 1995</a>; <a href="./references#CD007720-bbs2-0010" title="MikamiK , SuzukiM , KitagawaH , KawakamiM , HirotaN , YamaguchiH . Efficacy of corticosteroids in the treatment of community‐acquired pneumonia requiring hospitalisation. Lung2007;185(5):249‐55. ">Mikami 2007</a>; <a href="./references#CD007720-bbs2-0011" title="NafaeRM , RagabMI , AmanyFM , RashedSB . Adjuvant role of corticosteroids in the treatment of community‐acquired pneumonia. Egyptian Journal of Chest Diseases and Tuberculosis2013;62(3):439–45. ">Nafae 2013</a>; <a href="./references#CD007720-bbs2-0013" title="SabryNA , OmarEE . Corticosteroids and ICU course of community acquired pneumonia in Egyptian settings. Pharmacology &amp; Pharmacy2011;2:73‐81. [DOI: 10.4236/pp.2011.22009] ">Sabry 2011</a>; <a href="./references#CD007720-bbs2-0014" title="SnijdersD , DanielsJM , deGraaffCS , van derWerfTS , BoersmaWG . Efficacy of corticosteroids in community‐acquired pneumonia: a randomized double‐blinded clinical trial. American Journal of Respiratory and Critical Care Medicine2010;181(9):975‐82. ">Snijders 2010</a>; <a href="./references#CD007720-bbs2-0016" title="VanWoenselJB , vanAalderenWM , deWeerdW , JansenNJ . Dexamethasone for treatment of patients mechanically ventilated for lower respiratory tract infection caused by respiratory syncytial virus. Thorax2003;58(5):383‐7. ">Van Woensel 2003</a>; <a href="./references#CD007720-bbs2-0017" title="WuYJ , SunJ , ZhangJH , FengLL . Clinical efficacy of adjuvant therapy with glucocorticoids in children with lobar pneumonia caused by Mycoplasma pneumoniae . Zhongguo Dang Dai Er Ke Za Zhi [Chinese Journal of Contemporary Pediatrics]2014;16(4):401‐5. ">Wu 2014</a>). We assessed four trials in which outcome assessors were not blinded as at high risk of bias (<a href="./references#CD007720-bbs2-0006" title="LuoZ , LuoJ , LiuE , XuX , LiuY , ZengF , et al. Effects of prednisolone on refractory Mycoplasma pneumoniae pneumonia in children. Pediatric Pulmonology2014;49(4):377‐80. ">Luo 2014</a>; <a href="./references#CD007720-bbs2-0007" title="MarikP , KrausP , SribanteJ , HavlikI , LipmanJ , JohnsonDW . Hydrocortisone and tumour necrosis factor in severe community‐acquired pneumonia. A randomised controlled study. Chest1993;104(2):389‐92. ">Marik 1993</a>; <a href="./references#CD007720-bbs2-0008" title="McHardyVU , SchonellME . Ampicillin dosage and use of prednisolone in treatment of pneumonia: co‐operative controlled trial. British Medical Journal1972;4(5840):569‐73. ">McHardy 1972</a>; <a href="./references#CD007720-bbs2-0012" title="NagyB , GasparI , PappA , BeneZ , NagyBJr , VokoZ , et al. Efficacy of methylprednisolone in children with severe community acquired pneumonia. Pediatric Pulmonology2013;48(2):168‐75. ">Nagy 2013</a>). </p> </section> <section id="CD007720-sec-0082"> <h4 class="title">Incomplete outcome data</h4> <p>Eleven trials provided full intention‐to‐treat analysis (all randomly assigned participants were included in the analysis for mortality). In five trials there was postrandomisation exclusion of participants, but numbers of dropouts were given per study arm and reasons for exclusion were provided (<a href="./references#CD007720-bbs2-0001" title="BlumCA , NigroN , BrielM , SchuetzP , UllmerE , Suter‐WidmerI , et al. Adjunct prednisone therapy for patients with community‐acquired pneumonia: a multicentre, double‐blind, randomised, placebo‐controlled trial. Lancet2015;385(9977):1511‐8. ">Blum 2015</a>; <a href="./references#CD007720-bbs2-0002" title="ConfalonieriM , UrbinoR , PotenaA , PiattellaM , ParigiP , PuccioG . Hydrocortisone infusion for severe community‐acquired pneumonia: a preliminary randomised study. American Journal of Respiratory and Critical Care Medicine2005;171(3):242‐8. ">Confalonieri 2005</a>; <a href="./references#CD007720-bbs2-0004" title="Fernández‐SerranoS , DorcaJ , Garcia‐VidalC , Fernández‐SabéN , CarratalàJ , Fernández‐AgüeraA , et al. Effect of corticosteroids on the clinical course of community‐acquired pneumonia: a randomized controlled trial. Critical Care2011;15(2):R96. ">Fernández‐Serrano 2011</a>; <a href="./references#CD007720-bbs2-0015" title="TorresA , SibilaO , FerrerM , PolverinoE , MenendezR , MensaJ , et al. Effect of corticosteroids on treatment failure among hospitalized patients with severe community‐acquired pneumonia and high inflammatory response: a randomized clinical trial. JAMA2015;313(7):677‐86. ">Torres 2015</a>; <a href="./references#CD007720-bbs2-0016" title="VanWoenselJB , vanAalderenWM , deWeerdW , JansenNJ . Dexamethasone for treatment of patients mechanically ventilated for lower respiratory tract infection caused by respiratory syncytial virus. Thorax2003;58(5):383‐7. ">Van Woensel 2003</a>), therefore we judged these trials as at low risk of attrition bias. <a href="./references#CD007720-bbs2-0008" title="McHardyVU , SchonellME . Ampicillin dosage and use of prednisolone in treatment of pneumonia: co‐operative controlled trial. British Medical Journal1972;4(5840):569‐73. ">McHardy 1972</a> reported postrandomisation exclusions, but did not provide the number and study arm distribution of these participants and was therefore judged as at unclear risk of bias. </p> </section> <section id="CD007720-sec-0083"> <h4 class="title">Selective reporting</h4> <p>Trial registries were available for seven studies conducted from 2010 onwards (<a href="./references#CD007720-bbs2-0001" title="BlumCA , NigroN , BrielM , SchuetzP , UllmerE , Suter‐WidmerI , et al. Adjunct prednisone therapy for patients with community‐acquired pneumonia: a multicentre, double‐blind, randomised, placebo‐controlled trial. Lancet2015;385(9977):1511‐8. ">Blum 2015</a>; <a href="./references#CD007720-bbs2-0004" title="Fernández‐SerranoS , DorcaJ , Garcia‐VidalC , Fernández‐SabéN , CarratalàJ , Fernández‐AgüeraA , et al. Effect of corticosteroids on the clinical course of community‐acquired pneumonia: a randomized controlled trial. Critical Care2011;15(2):R96. ">Fernández‐Serrano 2011</a>; <a href="./references#CD007720-bbs2-0009" title="MeijvisSC , HardemanH , RemmeltsHH , HeijligenbergR , RijkersGT , vanVelzen‐BladH , et al. Dexamethasone and length of hospital stay in patients with community‐acquired pneumonia: a randomised, double‐blind, placebo‐controlled trial. Lancet2011;377(9782):2023‐30. ">Meijvis 2011</a>; <a href="./references#CD007720-bbs2-0012" title="NagyB , GasparI , PappA , BeneZ , NagyBJr , VokoZ , et al. Efficacy of methylprednisolone in children with severe community acquired pneumonia. Pediatric Pulmonology2013;48(2):168‐75. ">Nagy 2013</a>; <a href="./references#CD007720-bbs2-0013" title="SabryNA , OmarEE . Corticosteroids and ICU course of community acquired pneumonia in Egyptian settings. Pharmacology &amp; Pharmacy2011;2:73‐81. [DOI: 10.4236/pp.2011.22009] ">Sabry 2011</a>; <a href="./references#CD007720-bbs2-0014" title="SnijdersD , DanielsJM , deGraaffCS , van derWerfTS , BoersmaWG . Efficacy of corticosteroids in community‐acquired pneumonia: a randomized double‐blinded clinical trial. American Journal of Respiratory and Critical Care Medicine2010;181(9):975‐82. ">Snijders 2010</a>; <a href="./references#CD007720-bbs2-0015" title="TorresA , SibilaO , FerrerM , PolverinoE , MenendezR , MensaJ , et al. Effect of corticosteroids on treatment failure among hospitalized patients with severe community‐acquired pneumonia and high inflammatory response: a randomized clinical trial. JAMA2015;313(7):677‐86. ">Torres 2015</a>). Only one of these seven studies prespecified all study outcomes in the registry (<a href="./references#CD007720-bbs2-0004" title="Fernández‐SerranoS , DorcaJ , Garcia‐VidalC , Fernández‐SabéN , CarratalàJ , Fernández‐AgüeraA , et al. Effect of corticosteroids on the clinical course of community‐acquired pneumonia: a randomized controlled trial. Critical Care2011;15(2):R96. ">Fernández‐Serrano 2011</a>), therefore we judged the remaining studies as at high risk of reporting bias. Of the trials that did not have a registry, most were conducted before mandatory trial registry, but three were relatively new trials and were therefore judged as being at high risk of reporting bias as well (<a href="./references#CD007720-bbs2-0006" title="LuoZ , LuoJ , LiuE , XuX , LiuY , ZengF , et al. Effects of prednisolone on refractory Mycoplasma pneumoniae pneumonia in children. Pediatric Pulmonology2014;49(4):377‐80. ">Luo 2014</a>; <a href="./references#CD007720-bbs2-0011" title="NafaeRM , RagabMI , AmanyFM , RashedSB . Adjuvant role of corticosteroids in the treatment of community‐acquired pneumonia. Egyptian Journal of Chest Diseases and Tuberculosis2013;62(3):439–45. ">Nafae 2013</a>; <a href="./references#CD007720-bbs2-0017" title="WuYJ , SunJ , ZhangJH , FengLL . Clinical efficacy of adjuvant therapy with glucocorticoids in children with lobar pneumonia caused by Mycoplasma pneumoniae . Zhongguo Dang Dai Er Ke Za Zhi [Chinese Journal of Contemporary Pediatrics]2014;16(4):401‐5. ">Wu 2014</a>). Of the older trials without a registry, only <a href="./references#CD007720-bbs2-0016" title="VanWoenselJB , vanAalderenWM , deWeerdW , JansenNJ . Dexamethasone for treatment of patients mechanically ventilated for lower respiratory tract infection caused by respiratory syncytial virus. Thorax2003;58(5):383‐7. ">Van Woensel 2003</a> had full agreement in outcomes between methods and results, hence we judged the remaining studies as at high risk of reporting bias. </p> </section> <section id="CD007720-sec-0084"> <h4 class="title">Other potential sources of bias</h4> <p>Eight studies reported on sample size calculations and were classified as being at low risk of other potential sources of bias (<a href="./references#CD007720-bbs2-0001" title="BlumCA , NigroN , BrielM , SchuetzP , UllmerE , Suter‐WidmerI , et al. Adjunct prednisone therapy for patients with community‐acquired pneumonia: a multicentre, double‐blind, randomised, placebo‐controlled trial. Lancet2015;385(9977):1511‐8. ">Blum 2015</a>; <a href="./references#CD007720-bbs2-0004" title="Fernández‐SerranoS , DorcaJ , Garcia‐VidalC , Fernández‐SabéN , CarratalàJ , Fernández‐AgüeraA , et al. Effect of corticosteroids on the clinical course of community‐acquired pneumonia: a randomized controlled trial. Critical Care2011;15(2):R96. ">Fernández‐Serrano 2011</a>; <a href="./references#CD007720-bbs2-0009" title="MeijvisSC , HardemanH , RemmeltsHH , HeijligenbergR , RijkersGT , vanVelzen‐BladH , et al. Dexamethasone and length of hospital stay in patients with community‐acquired pneumonia: a randomised, double‐blind, placebo‐controlled trial. Lancet2011;377(9782):2023‐30. ">Meijvis 2011</a>; <a href="./references#CD007720-bbs2-0010" title="MikamiK , SuzukiM , KitagawaH , KawakamiM , HirotaN , YamaguchiH . Efficacy of corticosteroids in the treatment of community‐acquired pneumonia requiring hospitalisation. Lung2007;185(5):249‐55. ">Mikami 2007</a>; <a href="./references#CD007720-bbs2-0012" title="NagyB , GasparI , PappA , BeneZ , NagyBJr , VokoZ , et al. Efficacy of methylprednisolone in children with severe community acquired pneumonia. Pediatric Pulmonology2013;48(2):168‐75. ">Nagy 2013</a>; <a href="./references#CD007720-bbs2-0014" title="SnijdersD , DanielsJM , deGraaffCS , van derWerfTS , BoersmaWG . Efficacy of corticosteroids in community‐acquired pneumonia: a randomized double‐blinded clinical trial. American Journal of Respiratory and Critical Care Medicine2010;181(9):975‐82. ">Snijders 2010</a>; <a href="./references#CD007720-bbs2-0015" title="TorresA , SibilaO , FerrerM , PolverinoE , MenendezR , MensaJ , et al. Effect of corticosteroids on treatment failure among hospitalized patients with severe community‐acquired pneumonia and high inflammatory response: a randomized clinical trial. JAMA2015;313(7):677‐86. ">Torres 2015</a>; <a href="./references#CD007720-bbs2-0016" title="VanWoenselJB , vanAalderenWM , deWeerdW , JansenNJ . Dexamethasone for treatment of patients mechanically ventilated for lower respiratory tract infection caused by respiratory syncytial virus. Thorax2003;58(5):383‐7. ">Van Woensel 2003</a>). <a href="./references#CD007720-bbs2-0002" title="ConfalonieriM , UrbinoR , PotenaA , PiattellaM , ParigiP , PuccioG . Hydrocortisone infusion for severe community‐acquired pneumonia: a preliminary randomised study. American Journal of Respiratory and Critical Care Medicine2005;171(3):242‐8. ">Confalonieri 2005</a> reported on sample size calculation but also reported on having an early stop for benefit, when the upper stopping boundary defined for stopping was crossed for the outcome of PaO₂:FiO₂, and was thus classified as being at high risk of other potential sources of bias. We classified the remaining eight studies as being at unclear risk of bias for this domain. </p> </section> </section> <section id="CD007720-sec-0085"> <h3 class="title" id="CD007720-sec-0085">Effects of interventions</h3> <p>See: <a href="./full#CD007720-tbl-0001"><b>Summary of findings for the main comparison</b> Corticosteroids compared to control for pneumonia</a> </p> <section id="CD007720-sec-0086"> <h4 class="title">Primary outcome</h4> <section id="CD007720-sec-0087"> <h5 class="title">1. All‐cause mortality</h5> <section id="CD007720-sec-0088"> <h6 class="title">Adults</h6> <p>All‐cause mortality was reported in 11 of the 13 trials that included adults (N = 1863). Corticosteroid therapy was associated with a significantly lower rate of all‐cause mortality compared to control (risk ratio (RR) 0.66, 95% confidence interval (CI) 0.47 to 0.92; I² = 0%, fixed‐effect model). Despite the lack of statistical heterogeneity in this analysis, the benefit was larger and statistically significant in studies with unclear allocation concealment methods (RR 0.36, 95% CI 0.19 to 0.71) compared to studies using low‐risk methods (RR 0.80, 95% CI 0.54 to 1.19; <a href="./references#CD007720-fig-0007" title="">Analysis 1.1</a>; moderate‐quality evidence) (<a href="./full#CD007720-tbl-0001">summary of findings Table for the main comparison</a>). No small‐studies effect was demonstrated in the funnel plot analysis (<a href="#CD007720-fig-0004">Figure 4</a>). </p> <div class="figure" id="CD007720-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Funnel plot of comparison: 1 Corticosteroids versus no treatment or placebo, outcome: 1.1 Mortality ‐ adults." data-id="CD007720-fig-0004" src="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/image_n/nCD007720-AFig-FIG04.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Corticosteroids versus no treatment or placebo, outcome: 1.1 Mortality ‐ adults. </p> </div> </div> </div> <section id="CD007720-sec-0089"> <p><b>Subgroup analyses</b></p> <p>Nine studies (995 participants) provided data on participants with severe pneumonia. All‐cause mortality was significantly lower for participants receiving corticosteroids compared to control (RR 0.58, 95% CI 0.40 to 0.84; I² = 12%, fixed‐effect model). We judged the quality of the evidence as moderate due to differences in effect estimates between low and unclear risk of bias (<a href="./references#CD007720-fig-0008" title="">Analysis 1.2</a>). Excluding <a href="./references#CD007720-bbs2-0002" title="ConfalonieriM , UrbinoR , PotenaA , PiattellaM , ParigiP , PuccioG . Hydrocortisone infusion for severe community‐acquired pneumonia: a preliminary randomised study. American Journal of Respiratory and Critical Care Medicine2005;171(3):242‐8. ">Confalonieri 2005</a>, which was stopped early due to significant difference between the groups based on predefined stopping rules, with 0 deaths in the steroid arm, did not significantly change the overall result (RR 0.65, 95% CI 0.44 to 0.95), but brought the difference between the trials at low risk or bias and unclear risk of bias to statistical significance (P = 0.03 for subgroup differences). Four trials reported mortality in participants with non‐severe pneumonia (868 participants). There was no significant difference between corticosteroid therapy and control (RR 0.95, 95% CI 0.45 to 2.00; fixed‐effect model). We graded the quality of the evidence as moderate due the large confidence intervals leading to uncertainty in the true effect estimate. In the meta‐regression analysis, higher mortality in the control arm was significantly associated with a larger effect of corticosteroids on mortality, with the ratio of log RRs decreasing by 0.217 for every 1% increase in the mortality rate of the control arm (P = 0.007, <a href="#CD007720-fig-0005">Figure 5</a>). </p> <div class="figure" id="CD007720-fig-0005"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 5</div> </div> <hr class="top"/><img alt="Meta‐regression of the log risk ratios for the effect of steroids on mortality against the mortality rate (%) in the control group." data-id="CD007720-fig-0005" src="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/image_n/nCD007720-AFig-FIG05.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Meta‐regression of the log risk ratios for the effect of steroids on mortality against the mortality rate (%) in the control group. </p> </div> </div> </div> <p>Most adult trials reporting on mortality used corticosteroid doses equivalent to 40 mg to 50 mg of prednisone per day, for 5 to 10 days. All studies included participants with CAP or HCAP. Participants with HAP or VAP were excluded, therefore subgroup analysis by place of acquisition was not possible. None of the studies provided mortality data for the subgroups of septic shock versus no septic shock and by specific pathogens, and only one study reported mortality in the subgroup of participants with chronic obstructive pulmonary disease (COPD) (<a href="./references#CD007720-bbs2-0001" title="BlumCA , NigroN , BrielM , SchuetzP , UllmerE , Suter‐WidmerI , et al. Adjunct prednisone therapy for patients with community‐acquired pneumonia: a multicentre, double‐blind, randomised, placebo‐controlled trial. Lancet2015;385(9977):1511‐8. ">Blum 2015</a>). In meta‐regression analyses for these factors, no significant association was found between the risk ratios in individual trials and percentage of participants with septic shock (six studies), COPD (nine studies, three of which excluded participants with COPD), or pathogens causing pneumonia (analysing the percentage of participants with documented <i>Pneumococcal</i> pneumonia, pneumonia caused by atypical bacteria or isolation of a virus). The percentage of participants with no microbiological documented infection was inversely associated with the effect of corticosteroids, but this association was not statistically significant. In a post hoc meta‐regression analysis according to mean age of study population, the effect was significantly smaller with increasing age, with the ratio of log RRs increasing by 0.05 for every 1% increase in the mean age (P = 0.018, <a href="#CD007720-fig-0006">Figure 6</a>). </p> <div class="figure" id="CD007720-fig-0006"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 6</div> </div> <hr class="top"/><img alt="Meta‐regression of the log risk ratios for the effect of steroids on mortality against the mean age in the study population." data-id="CD007720-fig-0006" src="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/image_n/nCD007720-AFig-FIG06.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Meta‐regression of the log risk ratios for the effect of steroids on mortality against the mean age in the study population. </p> </div> </div> </div> </section> </section> <section id="CD007720-sec-0090"> <h6 class="title">Children</h6> <p>There were no reported deaths in the four trials that included children (risk difference (RD) 0.00, 95% CI ‐0.03 to 0.03; 4 trials, 266 children, <a href="./references#CD007720-fig-0010" title="">Analysis 1.4</a>). </p> </section> </section> </section> <section id="CD007720-sec-0091"> <h4 class="title">Secondary outcomes</h4> <section id="CD007720-sec-0092"> <h5 class="title">1. Early clinical failure</h5> <section id="CD007720-sec-0093"> <h6 class="title">Adults</h6> <p>Six trials reported the outcome of early clinical failure (1324 participants). The definitions used in the trials varied and are reported in <a href="#CD007720-tbl-0002">Table 1</a>. There was a significantly lower rate of early clinical failure in participants treated with corticosteroids compared to controls (RR 0.40, 95% CI 0.23 to 0.7; random‐effects model). We found substantial heterogeneity in this analysis (<a href="./references#CD007720-fig-0011" title="">Analysis 1.5</a>, I² = 72%). We downgraded the quality of the data for this outcome to moderate due to inconsistency, despite the large effect. </p> <div class="table" id="CD007720-tbl-0002"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Study definitions for clinical failure and time to cure</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Study name</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Clinical failure definition</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time to clinical cure</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007720-bbs2-0001" title="BlumCA , NigroN , BrielM , SchuetzP , UllmerE , Suter‐WidmerI , et al. Adjunct prednisone therapy for patients with community‐acquired pneumonia: a multicentre, double‐blind, randomised, placebo‐controlled trial. Lancet2015;385(9977):1511‐8. ">Blum 2015</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Number of participants not reaching clinical stability on day 5.</p> <p>Clinical stability defined as stable vital signs for ≥ 24 hours. Stable vital signs were temperature of ≤ 37.8 °C, heart rate of ≤ 100 beats per min, spontaneous respiratory rate of ≤ 24 breaths per min, systolic blood pressure of ≥ 90 mm Hg (≥ 100 mm Hg for participants with hypertension) without vasopressor support, mental status back to level before occurrence of community‐acquired pneumonia, ability for oral intake, and adequate oxygenation on room air (PaO₂ ≥ 60 mm Hg or pulse oximetry ≥ 90%). </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time to clinical stability defined as stable vital signs for ≥ 24 hours.</p> <p>Stable vital signs were temperature of ≤ 37.8 °C, heart rate of ≤ 100 beats per min, spontaneous respiratory rate of ≤ 24 breaths per min, systolic blood pressure of ≥ 90 mm Hg (≥ 100 mm Hg for participants with hypertension) without vasopressor support, mental status back to level before occurrence of community‐acquired pneumonia, ability for oral intake, and adequate oxygenation on room air (PaO₂ ≥ 60 mm Hg or pulse oximetry ≥ 90%). </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007720-bbs2-0002" title="ConfalonieriM , UrbinoR , PotenaA , PiattellaM , ParigiP , PuccioG . Hydrocortisone infusion for severe community‐acquired pneumonia: a preliminary randomised study. American Journal of Respiratory and Critical Care Medicine2005;171(3):242‐8. ">Confalonieri 2005</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Number of participants not achieving PaO₂:FiO₂ improvement ≥ 100 mm Hg compared to study entry, evaluated at day 8 </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time to weaning from mechanical ventilation</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007720-bbs2-0003" title="El‐GhamrawyAH , ShokierMH , EsmatAA . Effects of low‐dose hydrocortisone in ICU patients with severe community‐acquired pneumonia. Egyptian Journal of Chest Diseases and Tuberculosis2006;55:91‐9. ">El‐Ghamrawy 2006</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not evaluated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time to weaning from mechanical ventilation</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007720-bbs2-0004" title="Fernández‐SerranoS , DorcaJ , Garcia‐VidalC , Fernández‐SabéN , CarratalàJ , Fernández‐AgüeraA , et al. Effect of corticosteroids on the clinical course of community‐acquired pneumonia: a randomized controlled trial. Critical Care2011;15(2):R96. ">Fernández‐Serrano 2011</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not evaluated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time to resolution of morbidity score, a semi‐quantitative score combining clinical and radiological variables (not detailed in the manuscript but reference provided) </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007720-bbs2-0006" title="LuoZ , LuoJ , LiuE , XuX , LiuY , ZengF , et al. Effects of prednisolone on refractory Mycoplasma pneumoniae pneumonia in children. Pediatric Pulmonology2014;49(4):377‐80. ">Luo 2014</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Number of participants with no infiltrate resolution at day 7</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time to resolution of hypoxaemia</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007720-bbs2-0011" title="NafaeRM , RagabMI , AmanyFM , RashedSB . Adjuvant role of corticosteroids in the treatment of community‐acquired pneumonia. Egyptian Journal of Chest Diseases and Tuberculosis2013;62(3):439–45. ">Nafae 2013</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Number of participants with no improvement at day 7 (improvement definition not provided)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time to weaning from mechanical ventilation</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007720-bbs2-0012" title="NagyB , GasparI , PappA , BeneZ , NagyBJr , VokoZ , et al. Efficacy of methylprednisolone in children with severe community acquired pneumonia. Pediatric Pulmonology2013;48(2):168‐75. ">Nagy 2013</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Number of participants not improving based on clinical and radiological status on day 7 </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time to fever resolution</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007720-bbs2-0010" title="MikamiK , SuzukiM , KitagawaH , KawakamiM , HirotaN , YamaguchiH . Efficacy of corticosteroids in the treatment of community‐acquired pneumonia requiring hospitalisation. Lung2007;185(5):249‐55. ">Mikami 2007</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not evaluated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time to fever resolution</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007720-bbs2-0013" title="SabryNA , OmarEE . Corticosteroids and ICU course of community acquired pneumonia in Egyptian settings. Pharmacology &amp; Pharmacy2011;2:73‐81. [DOI: 10.4236/pp.2011.22009] ">Sabry 2011</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Number of participants not achieving PaO₂:FiO₂ improvement ≥ 100 mm Hg compared to study entry, evaluated at day 8 </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time to weaning from mechanical ventilation</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007720-bbs2-0014" title="SnijdersD , DanielsJM , deGraaffCS , van derWerfTS , BoersmaWG . Efficacy of corticosteroids in community‐acquired pneumonia: a randomized double‐blinded clinical trial. American Journal of Respiratory and Critical Care Medicine2010;181(9):975‐82. ">Snijders 2010</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Number of participants with clinical failure at day 7.</p> <p>Clinical failure defined as: persistence or progression of all signs and symptoms that developed during the acute disease episode after randomisation, or the development of a new pulmonary or extrapulmonary infection, or the deterioration of chest radiography after randomisation, or death due to pneumonia, or the inability to complete the study owing to adverse events. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time to clinical stability defined as when all 4 of the following criteria were met: improvement of cough and shortness of breath, temperature &lt; 37.8 °C for at least 8 hours, declining serum C‐reactive protein levels, and adequate oral intake and gastrointestinal absorption. </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007720-bbs2-0015" title="TorresA , SibilaO , FerrerM , PolverinoE , MenendezR , MensaJ , et al. Effect of corticosteroids on treatment failure among hospitalized patients with severe community‐acquired pneumonia and high inflammatory response: a randomized clinical trial. JAMA2015;313(7):677‐86. ">Torres 2015</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Number of participants with treatment failure between 72 hours and 120 hours after treatment initiation.<br/> Treatment failure defined as radiographic progression (increase of ≥ 50% of pulmonary infiltrates compared with baseline), persistence of severe respiratory failure (PaO₂:FiO₂ &lt; 200 mm Hg, with respiratory rate ≥ 30 breaths/min in participants not intubated), development of shock, need for invasive mechanical ventilation not present at baseline, or death. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time to clinical stability defined as when all of the following criteria were met: temperature ≤ 37.2 °C, heart rate ≤ 100 beats/min, systolic blood pressure ≥ 90 mm Hg, and arterial oxygen tension ≥ 60 mm Hg when the participant was not receiving supplemental oxygen. In participants receiving oxygen therapy at home, stability was considered to be achieved when oxygen needs were the same as before admission. </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007720-bbs2-0016" title="VanWoenselJB , vanAalderenWM , deWeerdW , JansenNJ . Dexamethasone for treatment of patients mechanically ventilated for lower respiratory tract infection caused by respiratory syncytial virus. Thorax2003;58(5):383‐7. ">Van Woensel 2003</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not evaluated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Duration of supplemental oxygen need</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007720-bbs2-0017" title="WuYJ , SunJ , ZhangJH , FengLL . Clinical efficacy of adjuvant therapy with glucocorticoids in children with lobar pneumonia caused by Mycoplasma pneumoniae . Zhongguo Dang Dai Er Ke Za Zhi [Chinese Journal of Contemporary Pediatrics]2014;16(4):401‐5. ">Wu 2014</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not evaluated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time to fever resolution</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>FiO₂ = inspired oxygen concentration<br/> PaO₂ = partial pressure of oxygen in arterial blood </p> </div> </div> <section id="CD007720-sec-0094"> <p><b>Subgroup analyses</b></p> <p>Five trials including 419 participants provided data regarding early clinical failure in participants with severe pneumonia, and two trials including 905 participants reported this outcome in participants with non‐severe pneumonia. In both subgroups the rate of early clinical failure was significantly lower in the corticosteroid arm compared to control (RR 0.32, 95% CI 0.15 to 0.7; I² = 74% for severe pneumonia, and RR 0.68, 95% CI 0.56 to 0.83; I² = 0% for non‐severe pneumonia, random‐effects model; <a href="./references#CD007720-fig-0011" title="">Analysis 1.5</a>). Heterogeneity in the subgroup of severe pneumonia resulted from different magnitudes of benefit rather than from opposing direct of effects. We graded the evidence for both analyses as of high quality. </p> <p>The dose of corticosteroid used in most adult trials reporting on early clinical failure was equivalent to 40 mg to 50 mg of prednisone per day, for 5 to 10 days. Only <a href="./references#CD007720-bbs2-0002" title="ConfalonieriM , UrbinoR , PotenaA , PiattellaM , ParigiP , PuccioG . Hydrocortisone infusion for severe community‐acquired pneumonia: a preliminary randomised study. American Journal of Respiratory and Critical Care Medicine2005;171(3):242‐8. ">Confalonieri 2005</a> reported clinical failure in the subgroup of participants with septic shock. No trials reported on this outcome by pathogen or among participants with and without COPD. Meta‐regression analyses could not be fitted due to the paucity of studies reporting on the outcome and participant characteristics. </p> </section> </section> <section id="CD007720-sec-0095"> <h6 class="title">Children</h6> <p>The outcome of early clinical failure was reported in two studies (88 children) with definitions provided in <a href="#CD007720-tbl-0002">Table 1</a>, and was significantly lower in the corticosteroid group compared to the control group (RR 0.41, 95% CI 0.24 to 0.70; I² = 25%, fixed‐effect model; <a href="./references#CD007720-fig-0012" title="">Analysis 1.6</a>). We graded this analysis as high quality. </p> <p>In an analysis by allocation concealment among adults and children combined, early clinical failure was significantly lower in the corticosteroid arm both for trials with low risk of bias (RR 0.59, 95% CI 0.37 to 0.94) and trials with unclear risk RR 0.27, 95% CI 0.14 to 0.52; random‐effects model; <a href="./references#CD007720-fig-0013" title="">Analysis 1.7</a>). The number of studies was too small for a funnel plot analysis. </p> </section> </section> <section id="CD007720-sec-0096"> <h5 class="title">2. Time to clinical cure</h5> <section id="CD007720-sec-0097"> <h6 class="title">Adults</h6> <p>Nine trials reported time to clinical cure (1322 participants). We accepted the definitions provided in all studies (<a href="#CD007720-tbl-0002">Table 1</a>). Three trials reported this outcome as median with interquartile range (IQR) (<a href="./references#CD007720-bbs2-0001" title="BlumCA , NigroN , BrielM , SchuetzP , UllmerE , Suter‐WidmerI , et al. Adjunct prednisone therapy for patients with community‐acquired pneumonia: a multicentre, double‐blind, randomised, placebo‐controlled trial. Lancet2015;385(9977):1511‐8. ">Blum 2015</a>; <a href="./references#CD007720-bbs2-0004" title="Fernández‐SerranoS , DorcaJ , Garcia‐VidalC , Fernández‐SabéN , CarratalàJ , Fernández‐AgüeraA , et al. Effect of corticosteroids on the clinical course of community‐acquired pneumonia: a randomized controlled trial. Critical Care2011;15(2):R96. ">Fernández‐Serrano 2011</a>; <a href="./references#CD007720-bbs2-0015" title="TorresA , SibilaO , FerrerM , PolverinoE , MenendezR , MensaJ , et al. Effect of corticosteroids on treatment failure among hospitalized patients with severe community‐acquired pneumonia and high inflammatory response: a randomized clinical trial. JAMA2015;313(7):677‐86. ">Torres 2015</a>), and one trial reported median with range (<a href="./references#CD007720-bbs2-0002" title="ConfalonieriM , UrbinoR , PotenaA , PiattellaM , ParigiP , PuccioG . Hydrocortisone infusion for severe community‐acquired pneumonia: a preliminary randomised study. American Journal of Respiratory and Critical Care Medicine2005;171(3):242‐8. ">Confalonieri 2005</a>). For these trials, means and standard deviations (SDs) were estimated from the median value provided. The time to clinical cure was significantly shorter in the corticosteroid group compared to placebo, but we found substantial heterogeneity in this analysis (mean difference (MD) ‐1.83 days, 95% CI ‐2.45 to ‐1.21; I² = 83%, random‐effects model; <a href="./references#CD007720-fig-0014" title="">Analysis 1.8</a>). In a sensitivity analysis, excluding the trials that did not meet our predefined criteria for clinical cure did not significantly affect results. </p> </section> <section id="CD007720-sec-0098"> <h6 class="title">Children</h6> <p>Four trials reported time to clinical cure, of which three studies (225 children) evaluated bacterial pneumonia and one included 41 children with respiratory syncytial virus pneumonia. In one trial (<a href="./references#CD007720-bbs2-0012" title="NagyB , GasparI , PappA , BeneZ , NagyBJr , VokoZ , et al. Efficacy of methylprednisolone in children with severe community acquired pneumonia. Pediatric Pulmonology2013;48(2):168‐75. ">Nagy 2013</a>), mean and SD were estimated from the median and IQR. In the three trials evaluating bacterial pneumonia, time to clinical cure was significantly shorter in the corticosteroid arm compared to the control arm (MD ‐1.57 days, 95% CI ‐2.55 to ‐0.60 days; I² = 80%, random‐effects model; <a href="./references#CD007720-fig-0015" title="">Analysis 1.9</a>). <a href="./references#CD007720-bbs2-0016" title="VanWoenselJB , vanAalderenWM , deWeerdW , JansenNJ . Dexamethasone for treatment of patients mechanically ventilated for lower respiratory tract infection caused by respiratory syncytial virus. Thorax2003;58(5):383‐7. ">Van Woensel 2003</a>, which evaluated viral pneumonia, showed no effect of corticosteroids on time to clinical cure. Here we also accepted the study definitions for time to clinical cure, which were not compatible with our protocol definitions (<a href="#CD007720-tbl-0002">Table 1</a>). </p> </section> </section> <section id="CD007720-sec-0099"> <h5 class="title">3. Development of respiratory failure not present initially</h5> <p>The need for new non‐invasive or invasive mechanical ventilation, not present at onset of pneumonia, was reported in four adult trials (1030 participants) and was significantly lower in the corticosteroid arm compared to the control arm without heterogeneity (RR 0.40, 95% CI 0.20 to 0.77; fixed‐effect model; <a href="./references#CD007720-fig-0016" title="">Analysis 1.10</a>). </p> </section> <section id="CD007720-sec-0100"> <h5 class="title">4. Development of shock not present initially</h5> <p>The development of shock not present initially was reported in six adult trials (five including participants with severe pneumonia) and was significantly lower in the corticosteroid arm without heterogeneity (RR 0.18, 95% CI 0.09 to 0.34; fixed‐effect model; <a href="./references#CD007720-fig-0017" title="">Analysis 1.11</a>). </p> </section> <section id="CD007720-sec-0101"> <h5 class="title">5. Transfer to ICU among participants not admitted initially to the ICU</h5> <p>In the four adult trials (1164 participants) reporting the need for ICU transfer (2 included participants with non‐severe pneumonia), we found no significant difference between the corticosteroids and control arms (RR 0.73, 95% CI 0.45 to 1.18; I² = 0%, fixed‐effect model; <a href="./references#CD007720-fig-0018" title="">Analysis 1.12</a>). </p> </section> <section id="CD007720-sec-0102"> <h5 class="title">6. Duration of hospital stay for hospitalised participants</h5> <section id="CD007720-sec-0103"> <h6 class="title">Adults</h6> <p>The length of hospital stay was significantly shorter in the corticosteroid group compared to control (MD ‐2.91 days, 95% CI ‐4.92 to ‐0.89; 9 trials, 1658 participants; <a href="./references#CD007720-fig-0019" title="">Analysis 1.13</a>). We found considerable heterogeneity for this analysis (I² = 91%), analysed using the random‐effects model. Five of the trials provided median (range/IQR) values for this outcome, and means with standard deviations were calculated or requested from authors. </p> </section> <section id="CD007720-sec-0104"> <h6 class="title">Children</h6> <p>One trial including children with bacterial pneumonia, <a href="./references#CD007720-bbs2-0012" title="NagyB , GasparI , PappA , BeneZ , NagyBJr , VokoZ , et al. Efficacy of methylprednisolone in children with severe community acquired pneumonia. Pediatric Pulmonology2013;48(2):168‐75. ">Nagy 2013</a>, and one trial including children with viral pneumonia, <a href="./references#CD007720-bbs2-0016" title="VanWoenselJB , vanAalderenWM , deWeerdW , JansenNJ . Dexamethasone for treatment of patients mechanically ventilated for lower respiratory tract infection caused by respiratory syncytial virus. Thorax2003;58(5):383‐7. ">Van Woensel 2003</a>, reported lengths of hospital stay. We did not pool results due to significant heterogeneity, with a significant benefit to steroids in the trial on bacterial pneumonia (MD ‐4.70 days with steroids, 95% CI ‐7.50 to ‐1.90) and no difference in the trial on viral pneumonia (<a href="./references#CD007720-fig-0021" title="">Analysis 1.15</a>). </p> </section> </section> <section id="CD007720-sec-0105"> <h5 class="title">7. Duration of ICU stay for participants admitted to the ICU</h5> <p>For adults who were admitted to the ICU (342 participants from 8 studies), ICU stay was significantly shorter in the corticosteroid group compared to control (MD ‐1.88 days, 95% CI ‐2.96 to ‐0.81; I² = 46%, fixed‐effect model; <a href="./references#CD007720-fig-0020" title="">Analysis 1.14</a>). Five trials provided median values (range/IQR) for this outcome, and means (SD) were calculated from these values. </p> </section> <section id="CD007720-sec-0106"> <h5 class="title">8. Pneumonia complications not present initially</h5> <p>Nine trials reported pneumonia complications, including eight adult trials (1573 participants) and one trial in children (59 children). Most trials defined this outcome as a combination of lung abscess, empyema or pleural effusion. One trial defined complications as septic shock or acute respiratory distress syndrome (ARDS) (<a href="./references#CD007720-bbs2-0011" title="NafaeRM , RagabMI , AmanyFM , RashedSB . Adjuvant role of corticosteroids in the treatment of community‐acquired pneumonia. Egyptian Journal of Chest Diseases and Tuberculosis2013;62(3):439–45. ">Nafae 2013</a>), and two trials evaluated this outcome without providing a definition. The rate of pneumonia complications was significantly lower for the corticosteroid arm when compared to controls (RR 0.58, 95% CI 0.40 to 0.84; I² = 43%, fixed‐effect model; <a href="./references#CD007720-fig-0022" title="">Analysis 1.16</a>). </p> </section> <section id="CD007720-sec-0107"> <h5 class="title">9. Secondary infections</h5> <p>For adults, we found no difference in the rate of secondary infections between the corticosteroid group and the control group (RR 1.19, 95% CI 0.73 to 1.93; 7 trials, 1533 participants, I² = 0%, fixed‐effect model; <a href="./references#CD007720-fig-0023" title="">Analysis 1.17</a>). All trials addressing this outcome in children had no reported cases of secondary infections (RD 0.00, 95% CI ‐0.03 to 0.03; 3 trials, 225 children; <a href="./references#CD007720-fig-0024" title="">Analysis 1.18</a>). </p> </section> <section id="CD007720-sec-0108"> <h5 class="title">10. Adverse events</h5> <section id="CD007720-sec-0109"> <h6 class="title">Adults</h6> <p>Three trials reported on any adverse event (1028 participants). There was a trend towards more adverse events in the corticosteroid arm compared to control, but with no statistical significance (RR 1.21, 95% CI 0.99 to 1.47; fixed‐effect model; <a href="./references#CD007720-fig-0025" title="">Analysis 1.19</a>). Hyperglycaemia developed significantly more frequently in the corticosteroid arm (RR 1.72, 95% CI 1.38 to 2.14; 7 trials, 1578 participants, I² = 0%, fixed‐effect model; <a href="./references#CD007720-fig-0026" title="">Analysis 1.20</a>). We found no significant difference between the two arms for gastrointestinal bleeding (RR 0.91, 95% CI 0.40 to 2.05; 7 trials, 1190 participants, fixed‐effect model; <a href="./references#CD007720-fig-0027" title="">Analysis 1.21</a>), neuropsychiatric adverse events (RR 1.95, 95% CI 0.70 to 5.42; 4 trials, 1149 participants, fixed‐effect model; <a href="./references#CD007720-fig-0028" title="">Analysis 1.22</a>), or adverse cardiac events (RR 0.6, 95% CI 0.32 to 1.13; 5 trials, 1249 participants, fixed‐effect model; <a href="./references#CD007720-fig-0029" title="">Analysis 1.23</a>). </p> </section> <section id="CD007720-sec-0110"> <h6 class="title">Children</h6> <p>No adverse events were reported in trials in children. Two trials reported no adverse event in either arm (<a href="./references#CD007720-fig-0030" title="">Analysis 1.24</a>), and one trial reported no cases of hyperglycaemia. </p> </section> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD007720-sec-0111" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD007720-sec-0111">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD007720-sec-0153">Español</a> </li> </nav> </div> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD007720-sec-0111"></div> <section id="CD007720-sec-0112"> <h3 class="title" id="CD007720-sec-0112">Summary of main results</h3> <p>In this review, we summarised the evidence on corticosteroid therapy, in addition to antibiotics, for pneumonia. Throughout the review, we separated the evidence for adults and children. </p> <p>For adults, corticosteroids significantly reduced mortality for participants with severe pneumonia (RR 0.58, 95% CI 0.40 to 0.84), number needed to treat for an additional beneficial outcome (NNTB) 18 patients (95% CI 12 to 49 patients). We assessed the quality of the evidence as moderate because unclear allocation concealment methods exaggerated effect estimates. There was no benefit or harm for steroids with non‐severe pneumonia (RR 0.95, 95% CI 0.45 to 2.00). Overall, we found an association between the mean age of study population and the effect of corticosteroids such that the effect was significantly smaller with increasing age (P = 0.018). Early clinical failure, defined as lack of clinical or radiological improvement, or both, between days five and eight, was significantly reduced with corticosteroids for participants with severe and non‐severe pneumonia, but the benefit was larger and the NNTB was smaller for severe pneumonia (RR 0.32, 95% CI 0.15 to 0.7; NNTB 4, 95% CI 3 to 8 patients versus RR 0.68, 95% CI 0.56 to 0.83; NNTB 8, 95% CI 6 to 16 patients, respectively; high‐quality evidence). Corticosteroids reduced the time to clinical cure, length of hospital stay, and length of ICU stay for participants admitted to the ICU. Similarly, the development of respiratory failure necessitating mechanical ventilation, the development of shock not present at pneumonia onset, and the rate of pneumonia complications, mostly pyogenic (RR 0.58, 95% CI 0.40 to 0.84), were reduced among corticosteroid‐treated participants. Of the adverse events, only hyperglycaemia was significantly more common among corticosteroids‐treated participants (RR 1.72, 95% CI 1.38 to 2.14). There was no significant difference between groups for gastrointestinal, neuropsychiatric, and cardiac adverse events and superinfections (RR 1.19, 95% CI 0.73 to 1.93). </p> <p>The paediatric trials were few and heterogenous, two including only children with <i>M pneumoniae</i> pneumonia (<a href="./references#CD007720-bbs2-0006" title="LuoZ , LuoJ , LiuE , XuX , LiuY , ZengF , et al. Effects of prednisolone on refractory Mycoplasma pneumoniae pneumonia in children. Pediatric Pulmonology2014;49(4):377‐80. ">Luo 2014</a>; <a href="./references#CD007720-bbs2-0017" title="WuYJ , SunJ , ZhangJH , FengLL . Clinical efficacy of adjuvant therapy with glucocorticoids in children with lobar pneumonia caused by Mycoplasma pneumoniae . Zhongguo Dang Dai Er Ke Za Zhi [Chinese Journal of Contemporary Pediatrics]2014;16(4):401‐5. ">Wu 2014</a>), one children with any pneumonia (<a href="./references#CD007720-bbs2-0012" title="NagyB , GasparI , PappA , BeneZ , NagyBJr , VokoZ , et al. Efficacy of methylprednisolone in children with severe community acquired pneumonia. Pediatric Pulmonology2013;48(2):168‐75. ">Nagy 2013</a>), and one children with severe respiratory syncytial virus pneumonitis/pneumonia (<a href="./references#CD007720-bbs2-0022" title="VanWoenselJB , VyasH , STAR Trial Group. Dexamethasone in children mechanically ventilated for lower respiratory tract infection caused by respiratory syncytial virus: a randomized controlled trial. Critical Care Medicine2011;39(7):1779‐83. ">Van Woensel 2011</a>). There were no deaths in these trials. In the bacterial pneumonia trials, corticosteroids reduced early clinical failure rates (RR 0.41, 95% CI 0.24 to 0.70; high‐quality evidence) and shortened the time to clinical cure. In the single trial assessing children with respiratory syncytial virus, no benefit with regard to time to clinical cure was observed with corticosteroids. No adverse events were reported. </p> </section> <section id="CD007720-sec-0113"> <h3 class="title" id="CD007720-sec-0113">Overall completeness and applicability of evidence</h3> <p>The inclusion criteria for this review were designed to include all types of pneumonia; the search was not limited by participant age, place of acquisition of pneumonia, or the type of pathogen causing it. However, the completeness of the results is affected by the trials found and types of pneumonia studied. The results of this review apply only to hospitalised CAP and HCAP. We included adult and paediatric trials, but separated the analyses due to the differences between them in terms of outcomes. The reported rates of death from CAP in children are as low as 0.01% to 0.001% (<a href="./references#CD007720-bbs2-0050" title="LeeGE , LorchSA , Sheffler‐CollinsS , KronmanMP , ShahSS . National hospitalization trends for pediatric pneumonia and associated complications. Pediatrics2010;126(2):204‐13. ">Lee 2010</a>), compared to 10% to 12% in adults (<a href="./references#CD007720-bbs2-0060" title="MusherDM , ThornerAR . Community‐acquired pneumonia. New England Journal of Medicine2014;271(17):1619‐28. ">Musher 2014</a>). Indeed, none of the paediatric trials included in our review reported deaths or complications as defined in this review. </p> <p>Among adults, there is an overall advantage to corticosteroid therapy. The question remains as to whom this benefit applies: who are the patients that will gain from corticosteroid therapy when hospitalised with CAP/HCAP? The first clear group to emerge is those with severe pneumonia defined using ATS/IDSA or BTS criteria (<a href="./references#CD007720-bbs2-0034" title="British Thoracic Society. Community‐acquired pneumonia in adults in British hospitals in 1982‐1983: a survey of aetiology, mortality, prognostic factors and outcome. The British Thoracic Society and the Public Health Laboratory Service. Quarterly Journal of Medicine1987;62(239):195‐220. ">BTS guidelines 1987</a>; <a href="./references#CD007720-bbs2-0054" title="MandellLA , WunderinkRG , AnzuetoA , BartlettJG , CampbellGD , DeanNC , et al. Infectious Diseases Society of America. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community‐acquired pneumonia in adults. Clinical Infectious Diseases2007;44(Suppl 2):S27‐72. ">Mandell 2007</a>). Among patients with severe CAP/HCAP, 18 patients need to be treated to prevent one death and four to prevent one clinical failure at five to eight days. The corticosteroid regimen most commonly used in these trials was an intravenous (IV) formulation equivalent to 40 mg to 50 mg of prednisone per day for five to 10 days. Few trials used higher dosing, up to 90 mg of prednisone‐equivalents a day, and one old trial used a single dose of IV hydrocortisone 10 mg/kg (<a href="./references#CD007720-bbs2-0007" title="MarikP , KrausP , SribanteJ , HavlikI , LipmanJ , JohnsonDW . Hydrocortisone and tumour necrosis factor in severe community‐acquired pneumonia. A randomised controlled study. Chest1993;104(2):389‐92. ">Marik 1993</a>). Corticosteroid therapy has been shown to reduce mortality rates in people with septic shock (<a href="./references#CD007720-bbs2-0030" title="AnnaneD , BellissantE , BollaertPE , BriegelJ , ConfalonieriM , DeGaudioR , et al. Corticosteroids in the treatment of severe sepsis and septic shock in adults: a systematic review. JAMA2009;301(22):2362. ">Annane 2009</a>), and have conflicting effects on people with ARDS (<a href="./references#CD007720-bbs2-0068" title="RuanSY , LinHH , HuangCT , KuoPH , WuHD , YuCJ . Exploring the heterogeneity of effects of corticosteroids on acute respiratory distress syndrome: a systematic review and meta‐analysis. Critical Care2014;18(2):R63. ">Ruan 2014</a>). The Surviving Sepsis Campaign Guidelines recommend IV hydrocortisone at a dose of 200 mg per day to people with septic shock not restoring haemodynamic stability after adequate fluid resuscitation and vasopressor therapy (<a href="./references#CD007720-bbs2-0066" title="RhodesA , EvansLE , AlhazzaniW , LevyMM , AntonelliM , FerrerR , et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Critical Care Medicine2017;45(3):486‐552. ">Rhodes 2017</a>). It is not possible to determine to what extent the effect of corticosteroids on mortality in severely ill patients is explained by its effect on septic shock or ARDS. However, meta‐regression did not show an association between the percentage of patients with septic shock and the effect of corticosteroid therapy on mortality, pointing at the possible contribution of corticosteroid in pneumonia independent of septic shock. People with pneumonia and septic shock have, by definition, severe pneumonia, and the same steroid regimen applies to both, except that with septic shock the recommendations are to continue steroids until haemodynamic stability is reached followed by tapering off. </p> <p>Some people with pneumonia may be affected by corticosteroid therapy differently than others. Corticosteroids have been shown to significantly reduce failure among people with COPD exacerbation, but not mortality (<a href="./references#CD007720-bbs2-0075" title="WaltersJA , TanDJ , WhiteCJ , GibsonPG , Wood‐BakerR , WaltersEH . Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews2014, Issue 9. [DOI: 10.1002/14651858.CD001288.pub4] ">Walters 2014</a>), thus people with COPD exacerbation and CAP might gain more from corticosteroid therapy than other patients. We could not perform a subgroup analysis to determine if there is a difference in the effect of corticosteroids in patients with or without COPD due to the paucity of trials providing relevant data. A meta‐regression analysis did not show an association between the percentage of participants with COPD in the trials and corticosteroid effects on mortality. To note, three trials excluded people with COPD. </p> <p>People with diabetes mellitus may be adversely affected by corticosteroid therapy by being more prone to hyperglycaemia and its detrimental effect on survival in acutely ill patients (<a href="./references#CD007720-bbs2-0049" title="KrinsleyJS . Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. Mayo Clinic Proceedings2003;78(12):1471. ">Krinsley 2003</a>). We did not perform subgroup analyses according to this confounder due to the paucity of outcome data. Overall, hyperglycaemia was significantly more common with corticosteroids. </p> <p>Elderly patients with pneumonia have higher rates of treatment failure, need for intensive care, and mortality (<a href="./references#CD007720-bbs2-0048" title="KaplanV , AngusDC , GriffinMF , ClermontG , Scott WatsonR , Linde‐ZwirbleWT . Hospitalized community‐acquired pneumonia in the elderly: age‐ and sex‐related patterns of care and outcome in the United States. American Journal of Respiratory and Critical Care Medicine2002;165(6):766‐72. ">Kaplan 2002</a>). The trials included in this review were not limited by age definitions, but as previously shown, participants' mean age in these randomised controlled trials was lower than that of people treated for CAP in clinical practice (<a href="./references#CD007720-bbs2-0032" title="AvniT , Shiver‐OferS , LeiboviciL , TacconelliE , DeAngelisG , CooksonB , et al. Participation of elderly adults in randomized controlled trials addressing antibiotic treatment of pneumonia. Journal of the American Geriatrics Society2015;63(2):233‐43. ">Avni 2015</a>). There were no outcome data by age subgroup, but by meta‐regression we observed decreasing effects of corticosteroid therapy on mortality with increasing mean age of the trials' population, denoting a smaller survival benefit with aging. This finding could be linked to more diabetes with increasing age, the neuropsychiatric effects of corticosteroids (although not shown in the overall analysis), or different inflammatory response in elderly patients. </p> <p>The pathogenesis of pneumonia may be different with different causative pathogens. The inflammatory response caused by bacterial pneumonia is thus different from that caused by viral pneumonia, and the radiographic presentation of 'atypical' bacteria is different from that of <i>S pneumoniae</i> or other bacteria causing pneumonia (<a href="./references#CD007720-bbs2-0074" title="VirkkiR , JuvenT , RikalainenH , SvedströmE , MertsolaJ , RuuskanenO . Differentiation of bacterial and viral pneumonia in children. Thorax2002;57(5):438‐41. ">Virkki 2002</a>). None of the adult trials included in this review restricted the inclusion to specific pathogens, and none reported relevant outcome data by pathogen. Meta‐regression analyses did not show associations between corticosteroid effects and the percentage of participants in the trials with the different pathogens. However, these analyses were also limited by the fact that the bacterial aetiology of CAP/HCAP is frequently unknown, and data were frequently not reported. Some of the cases of pneumonia with no microbiological documented infection may actually represent pulmonary infiltrates of a non‐infectious, inflammatory aetiology (e.g. organising pneumonia). A possible theory might be that the effect of corticosteroids in pneumonia is at least partially driven by its effect on the subset of patients with non‐infectious pneumonia. Our results do not support this hypothesis. </p> <p>The heterogeneity in the paediatric trials precludes strong conclusions for children with CAP. Overall, a significant benefit was demonstrated with regard to early clinical failure, pointing at the potential of this intervention. However, we were unable to define the children likely to benefit from corticosteroids and the dose and duration from the available trials. </p> </section> <section id="CD007720-sec-0114"> <h3 class="title" id="CD007720-sec-0114">Quality of the evidence</h3> <p>The results for the main outcomes and the quality of evidence assessments are summarised in <a href="./full#CD007720-tbl-0001">summary of findings Table for the main comparison</a>. For the primary outcome of mortality, we assessed all analyses as of moderate quality. For the outcome of early clinical failure, we assessed the quality of the main analysis as moderate. However, we judged the analyses of severe pneumonia, non‐severe pneumonia, and paediatric participants as high quality. Several reasons led us to downgrade the quality of the evidence. Some of the trials included in the review had unclear allocation concealment. We downgraded the evidence quality for risk of bias when a sensitivity analysis implied that unclear allocation concealment exaggerated the effect of corticosteroids, but not when such an effect was not evident. We downgraded quality for imprecision whenever the 95% CI overlapped no effect with a wide confidence interval so that harm caused by corticosteroids could not have been ruled out, and for inconsistency whenever considerable heterogeneity was found. In cases of a risk ratio lower than 0.5, we upgraded the quality of the evidence by one level. </p> </section> <section id="CD007720-sec-0115"> <h3 class="title" id="CD007720-sec-0115">Potential biases in the review process</h3> <p>This review has a few limitations that should be noted. For most predefined subgroups, lack of data precluded us from performing subgroup analyses. Only two trials provided mortality data per study arm in the subgroups of severe and non‐severe pneumonia (<a href="./references#CD007720-bbs2-0001" title="BlumCA , NigroN , BrielM , SchuetzP , UllmerE , Suter‐WidmerI , et al. Adjunct prednisone therapy for patients with community‐acquired pneumonia: a multicentre, double‐blind, randomised, placebo‐controlled trial. Lancet2015;385(9977):1511‐8. ">Blum 2015</a>; <a href="./references#CD007720-bbs2-0014" title="SnijdersD , DanielsJM , deGraaffCS , van derWerfTS , BoersmaWG . Efficacy of corticosteroids in community‐acquired pneumonia: a randomized double‐blinded clinical trial. American Journal of Respiratory and Critical Care Medicine2010;181(9):975‐82. ">Snijders 2010</a>). For the remaining trials we classified the trial as including severe or non‐severe pneumonia participants according to the mortality rate in the control arm. Hence, for most trials the classification is at the trial level and not at the participant level. Furthermore, mortality, although reflecting the severity of pneumonia, may be influenced by other parameters such as the antibiotic regimens used or the standard of medical care given in the specific centre. Nevertheless, we found a good correlation between the trials' percentage of participants with Pneumonia Severity Index four to five and our severity classification based on mortality (data not shown). To note, one of the trials that included people with severe pneumonia by its own definition was actually classified as non‐severe pneumonia according to the mortality rate in the control arm (<a href="./references#CD007720-bbs2-0004" title="Fernández‐SerranoS , DorcaJ , Garcia‐VidalC , Fernández‐SabéN , CarratalàJ , Fernández‐AgüeraA , et al. Effect of corticosteroids on the clinical course of community‐acquired pneumonia: a randomized controlled trial. Critical Care2011;15(2):R96. ">Fernández‐Serrano 2011</a>). </p> <p>In place of subgroup analyses, we performed meta‐regression. The primary outcome of mortality was reported in 11 out of the 13 adult trials, thus meta‐regression analyses could have been done for this outcome, but not for the secondary outcomes, which were reported in fewer trials. Meta‐regression analyses may contribute to the understanding of the association between specific confounders and the effect, but they should be regarded as observational, and provide only trial‐level evidence as opposed to the patient‐level evidence provided by randomised controlled trials. </p> <p>We chose all‐cause mortality as the primary outcome, assuming it to be the most objective outcome and the most relevant outcome to patients. This is true for the adult population, but not for the paediatric trials, where mortality cannot be analysed because of the very low event rate. </p> <p>For the outcomes of early clinical failure and time to clinical cure, we allowed some diversity in the outcome definitions and accepted definitions that did not meet the strict predefined criteria of the review. This may lead to an indirectness bias. For example, we accepted fever resolution as a surrogate for clinical cure. It is true that a patient would not be held as cured while still febrile, but the opposite might not be true, as a patient may be afebrile but not cured. </p> <p>For some continuous outcomes, we had to estimate means from medians to perform meta‐analysis. This is imprecise, since these outcomes were reported as medians due to their skewed distribution. These analyses should thus be viewed with caution. </p> <p>The dose and schedule of corticosteroids administered varied, as shown in the <a href="./references#CD007720-sec-0135" title="">Characteristics of included studies</a> table. We did not account for this variability in our analysis, assuming a common effect of different corticosteroid regimens. </p> </section> <section id="CD007720-sec-0116"> <h3 class="title" id="CD007720-sec-0116">Agreements and disagreements with other studies or reviews</h3> <p>The previous version of this review showed that corticosteroid therapy hastens the resolution of symptoms for people with pneumonia, but with no effect on mortality (<a href="./references#CD007720-bbs2-0082" title="ChenY , LiK , PuH , WuT . Corticosteroids for pneumonia. Cochrane Database of Systematic Reviews2011, Issue 3. [DOI: 10.1002/14651858.CD007720.pub2] ">Chen 2011</a>). In 2015, two relatively large, high‐quality randomised controlled trials evaluating corticosteroid for people with CAP were published. The first trial included people with severe pneumonia hospitalised mostly in the ICU and showed reduced clinical failure rates with corticosteroid therapy (<a href="./references#CD007720-bbs2-0015" title="TorresA , SibilaO , FerrerM , PolverinoE , MenendezR , MensaJ , et al. Effect of corticosteroids on treatment failure among hospitalized patients with severe community‐acquired pneumonia and high inflammatory response: a randomized clinical trial. JAMA2015;313(7):677‐86. ">Torres 2015</a>). The second trial included people with severe and non‐severe pneumonia (and provided separate outcome data) and showed shortened time to clinical stability with corticosteroids (<a href="./references#CD007720-bbs2-0001" title="BlumCA , NigroN , BrielM , SchuetzP , UllmerE , Suter‐WidmerI , et al. Adjunct prednisone therapy for patients with community‐acquired pneumonia: a multicentre, double‐blind, randomised, placebo‐controlled trial. Lancet2015;385(9977):1511‐8. ">Blum 2015</a>). Neither of the trials showed an effect on mortality. Since then, a few reviews and meta‐analyses assessing corticosteroid therapy in pneumonia have been published (<a href="./references#CD007720-bbs2-0045" title="HoritaN , OtsukaT , HaranagaS , NamkoongH , MikiM , MiyashitaN , et al. Adjunctive systemic corticosteroids for hospitalized community‐acquired pneumonia: systematic review and meta‐analysis 2015 update. Scientific Reports2015;5:14061. ">Horita 2015</a>; <a href="./references#CD007720-bbs2-0058" title="MartiC , GrosgurinO , HarbarthS , CombescureC , AbbasM , RutschmannO , et al. Adjunctive corticotherapy for community acquired pneumonia: a systematic review and meta‐analysis. PLoS ONE2015;10(12):e0144032. ">Marti 2015</a>; <a href="./references#CD007720-bbs2-0072" title="SiemieniukRA , MeadeMO , Alonso‐CoelloP , BrielM , EvaniewN , PrasadM , et al. Corticosteroid therapy for patients hospitalized with community‐acquired pneumonia: a systematic review and meta‐analysis. Annals of Internal Medicine2015;163(7):519‐28. ">Siemieniuk 2015</a>; <a href="./references#CD007720-bbs2-0077" title="WanYD , SunTW , LiuZQ , ZhangSG , WangLX , KanQC . Efficacy and safety of corticosteroids for community‐acquired pneumonia: a systematic review and meta‐analysis. Chest2016;149(1):209‐19. ">Wan 2016</a>), all showing benefit to corticosteroid therapy but to different extent. Our review adds several pieces of knowledge over previous reviews. First, we have shown the importance of allocation concealment even for the objective outcome of mortality. Trials that did not describe adequate methods of allocation concealment showed greater mortality reductions with corticosteroids, affecting the overall analysis of mortality. While <a href="./references#CD007720-bbs2-0072" title="SiemieniukRA , MeadeMO , Alonso‐CoelloP , BrielM , EvaniewN , PrasadM , et al. Corticosteroid therapy for patients hospitalized with community‐acquired pneumonia: a systematic review and meta‐analysis. Annals of Internal Medicine2015;163(7):519‐28. ">Siemieniuk 2015</a> graded the quality of the evidence for mortality as moderate, we added a GRADE appraisal of the evidence for the important subgroup of patients with severe pneumonia who benefit from corticosteroid therapy. The former reviews did not assess the outcome of early clinical failure. We showed that corticosteroids significantly reduce early clinical failure regardless of the pneumonia severity classification, but that the effect is larger in the subgroup of patients with severe pneumonia, a finding that strengthens the result of the mortality analysis. This is in opposition to <a href="./references#CD007720-bbs2-0072" title="SiemieniukRA , MeadeMO , Alonso‐CoelloP , BrielM , EvaniewN , PrasadM , et al. Corticosteroid therapy for patients hospitalized with community‐acquired pneumonia: a systematic review and meta‐analysis. Annals of Internal Medicine2015;163(7):519‐28. ">Siemieniuk 2015</a>, who assessed the need for mechanical ventilation as a secondary outcome and found a lower magnitude of effect in people with severe pneumonia. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD007720-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/urn:x-wiley:14651858:media:CD007720:CD007720-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/image_t/tCD007720-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD007720-fig-0001" src="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/image_n/nCD007720-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/full#CD007720-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/image_n/nCD007720-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007720-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/urn:x-wiley:14651858:media:CD007720:CD007720-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/image_t/tCD007720-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD007720-fig-0002" src="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/image_n/nCD007720-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/full#CD007720-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/image_n/nCD007720-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007720-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/urn:x-wiley:14651858:media:CD007720:CD007720-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/image_t/tCD007720-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD007720-fig-0003" src="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/image_n/nCD007720-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/full#CD007720-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/image_n/nCD007720-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007720-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/urn:x-wiley:14651858:media:CD007720:CD007720-AFig-FIG04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/image_t/tCD007720-AFig-FIG04.png" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of comparison: 1 Corticosteroids versus no treatment or placebo, outcome: 1.1 Mortality ‐ adults." data-id="CD007720-fig-0004" src="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/image_n/nCD007720-AFig-FIG04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Corticosteroids versus no treatment or placebo, outcome: 1.1 Mortality ‐ adults. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/full#CD007720-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/image_n/nCD007720-AFig-FIG04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007720-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/urn:x-wiley:14651858:media:CD007720:CD007720-AFig-FIG05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/image_t/tCD007720-AFig-FIG05.png" target="_blank"><b></b></a></p> </div><img alt="Meta‐regression of the log risk ratios for the effect of steroids on mortality against the mortality rate (%) in the control group." data-id="CD007720-fig-0005" src="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/image_n/nCD007720-AFig-FIG05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 5</div> <div class="figure-caption"> <p>Meta‐regression of the log risk ratios for the effect of steroids on mortality against the mortality rate (%) in the control group. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/full#CD007720-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/image_n/nCD007720-AFig-FIG05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007720-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/urn:x-wiley:14651858:media:CD007720:CD007720-AFig-FIG06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/image_t/tCD007720-AFig-FIG06.png" target="_blank"><b></b></a></p> </div><img alt="Meta‐regression of the log risk ratios for the effect of steroids on mortality against the mean age in the study population." data-id="CD007720-fig-0006" src="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/image_n/nCD007720-AFig-FIG06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 6</div> <div class="figure-caption"> <p>Meta‐regression of the log risk ratios for the effect of steroids on mortality against the mean age in the study population. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/full#CD007720-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/image_n/nCD007720-AFig-FIG06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007720-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/urn:x-wiley:14651858:media:CD007720:CD007720-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/image_t/tCD007720-CMP-001-01.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Corticosteroids versus no treatment or placebo, Outcome 1 Mortality ‐ adults." data-id="CD007720-fig-0007" src="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/image_n/nCD007720-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Corticosteroids versus no treatment or placebo, Outcome 1 Mortality ‐ adults. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/references#CD007720-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/image_n/nCD007720-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007720-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/urn:x-wiley:14651858:media:CD007720:CD007720-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/image_t/tCD007720-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Corticosteroids versus no treatment or placebo, Outcome 2 Mortality ‐ adults, severe pneumonia, by allocation concealment." data-id="CD007720-fig-0008" src="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/image_n/nCD007720-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Corticosteroids versus no treatment or placebo, Outcome 2 Mortality ‐ adults, severe pneumonia, by allocation concealment. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/references#CD007720-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/image_n/nCD007720-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007720-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/urn:x-wiley:14651858:media:CD007720:CD007720-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/image_t/tCD007720-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Corticosteroids versus no treatment or placebo, Outcome 3 Mortality ‐ adults, non‐severe pneumonia, by allocation concealment." data-id="CD007720-fig-0009" src="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/image_n/nCD007720-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Corticosteroids versus no treatment or placebo, Outcome 3 Mortality ‐ adults, non‐severe pneumonia, by allocation concealment. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/references#CD007720-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/image_n/nCD007720-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007720-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/urn:x-wiley:14651858:media:CD007720:CD007720-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/image_t/tCD007720-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Corticosteroids versus no treatment or placebo, Outcome 4 Mortality ‐ children." data-id="CD007720-fig-0010" src="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/image_n/nCD007720-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Corticosteroids versus no treatment or placebo, Outcome 4 Mortality ‐ children. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/references#CD007720-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/image_n/nCD007720-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007720-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/urn:x-wiley:14651858:media:CD007720:CD007720-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/image_t/tCD007720-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Corticosteroids versus no treatment or placebo, Outcome 5 Early clinical failure ‐ adults." data-id="CD007720-fig-0011" src="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/image_n/nCD007720-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Corticosteroids versus no treatment or placebo, Outcome 5 Early clinical failure ‐ adults. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/references#CD007720-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/image_n/nCD007720-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007720-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/urn:x-wiley:14651858:media:CD007720:CD007720-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/image_t/tCD007720-CMP-001-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Corticosteroids versus no treatment or placebo, Outcome 6 Early clinical failure ‐ children." data-id="CD007720-fig-0012" src="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/image_n/nCD007720-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 Corticosteroids versus no treatment or placebo, Outcome 6 Early clinical failure ‐ children. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/references#CD007720-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/image_n/nCD007720-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007720-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/urn:x-wiley:14651858:media:CD007720:CD007720-CMP-001-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/image_t/tCD007720-CMP-001-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Corticosteroids versus no treatment or placebo, Outcome 7 Early clinical failure ‐ adults + children by allocation concealment." data-id="CD007720-fig-0013" src="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/image_n/nCD007720-CMP-001-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1 Corticosteroids versus no treatment or placebo, Outcome 7 Early clinical failure ‐ adults + children by allocation concealment. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/references#CD007720-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/image_n/nCD007720-CMP-001-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007720-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/urn:x-wiley:14651858:media:CD007720:CD007720-CMP-001-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/image_t/tCD007720-CMP-001-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Corticosteroids versus no treatment or placebo, Outcome 8 Time to clinical cure ‐ adults." data-id="CD007720-fig-0014" src="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/image_n/nCD007720-CMP-001-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1 Corticosteroids versus no treatment or placebo, Outcome 8 Time to clinical cure ‐ adults. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/references#CD007720-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/image_n/nCD007720-CMP-001-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007720-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/urn:x-wiley:14651858:media:CD007720:CD007720-CMP-001-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/image_t/tCD007720-CMP-001-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Corticosteroids versus no treatment or placebo, Outcome 9 Time to clinical cure ‐ children." data-id="CD007720-fig-0015" src="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/image_n/nCD007720-CMP-001-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.9</div> <div class="figure-caption"> <p>Comparison 1 Corticosteroids versus no treatment or placebo, Outcome 9 Time to clinical cure ‐ children. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/references#CD007720-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/image_n/nCD007720-CMP-001-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007720-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/urn:x-wiley:14651858:media:CD007720:CD007720-CMP-001-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/image_t/tCD007720-CMP-001-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Corticosteroids versus no treatment or placebo, Outcome 10 Need for mechanical ventilation ‐ adults." data-id="CD007720-fig-0016" src="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/image_n/nCD007720-CMP-001-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.10</div> <div class="figure-caption"> <p>Comparison 1 Corticosteroids versus no treatment or placebo, Outcome 10 Need for mechanical ventilation ‐ adults. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/references#CD007720-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/image_n/nCD007720-CMP-001-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007720-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/urn:x-wiley:14651858:media:CD007720:CD007720-CMP-001-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/image_t/tCD007720-CMP-001-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Corticosteroids versus no treatment or placebo, Outcome 11 Development of shock ‐ adults." data-id="CD007720-fig-0017" src="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/image_n/nCD007720-CMP-001-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.11</div> <div class="figure-caption"> <p>Comparison 1 Corticosteroids versus no treatment or placebo, Outcome 11 Development of shock ‐ adults. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/references#CD007720-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/image_n/nCD007720-CMP-001-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007720-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/urn:x-wiley:14651858:media:CD007720:CD007720-CMP-001-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/image_t/tCD007720-CMP-001-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Corticosteroids versus no treatment or placebo, Outcome 12 Need for ICU transfer ‐ adults." data-id="CD007720-fig-0018" src="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/image_n/nCD007720-CMP-001-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.12</div> <div class="figure-caption"> <p>Comparison 1 Corticosteroids versus no treatment or placebo, Outcome 12 Need for ICU transfer ‐ adults. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/references#CD007720-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/image_n/nCD007720-CMP-001-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007720-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/urn:x-wiley:14651858:media:CD007720:CD007720-CMP-001-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/image_t/tCD007720-CMP-001-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Corticosteroids versus no treatment or placebo, Outcome 13 Length of hospitalisation ‐ adults." data-id="CD007720-fig-0019" src="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/image_n/nCD007720-CMP-001-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.13</div> <div class="figure-caption"> <p>Comparison 1 Corticosteroids versus no treatment or placebo, Outcome 13 Length of hospitalisation ‐ adults. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/references#CD007720-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/image_n/nCD007720-CMP-001-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007720-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/urn:x-wiley:14651858:media:CD007720:CD007720-CMP-001-14" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/image_t/tCD007720-CMP-001-14.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Corticosteroids versus no treatment or placebo, Outcome 14 Length of ICU stay ‐ adults." data-id="CD007720-fig-0020" src="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/image_n/nCD007720-CMP-001-14.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.14</div> <div class="figure-caption"> <p>Comparison 1 Corticosteroids versus no treatment or placebo, Outcome 14 Length of ICU stay ‐ adults. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/references#CD007720-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/image_n/nCD007720-CMP-001-14.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007720-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/urn:x-wiley:14651858:media:CD007720:CD007720-CMP-001-15" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/image_t/tCD007720-CMP-001-15.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Corticosteroids versus no treatment or placebo, Outcome 15 Length of hospitalisation ‐ children." data-id="CD007720-fig-0021" src="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/image_n/nCD007720-CMP-001-15.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.15</div> <div class="figure-caption"> <p>Comparison 1 Corticosteroids versus no treatment or placebo, Outcome 15 Length of hospitalisation ‐ children. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/references#CD007720-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/image_n/nCD007720-CMP-001-15.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007720-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/urn:x-wiley:14651858:media:CD007720:CD007720-CMP-001-16" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/image_t/tCD007720-CMP-001-16.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Corticosteroids versus no treatment or placebo, Outcome 16 Pneumonia complications ‐ adults + children." data-id="CD007720-fig-0022" src="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/image_n/nCD007720-CMP-001-16.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.16</div> <div class="figure-caption"> <p>Comparison 1 Corticosteroids versus no treatment or placebo, Outcome 16 Pneumonia complications ‐ adults + children. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/references#CD007720-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/image_n/nCD007720-CMP-001-16.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007720-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/urn:x-wiley:14651858:media:CD007720:CD007720-CMP-001-17" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/image_t/tCD007720-CMP-001-17.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Corticosteroids versus no treatment or placebo, Outcome 17 Secondary infections ‐ adults." data-id="CD007720-fig-0023" src="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/image_n/nCD007720-CMP-001-17.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.17</div> <div class="figure-caption"> <p>Comparison 1 Corticosteroids versus no treatment or placebo, Outcome 17 Secondary infections ‐ adults. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/references#CD007720-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/image_n/nCD007720-CMP-001-17.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007720-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/urn:x-wiley:14651858:media:CD007720:CD007720-CMP-001-18" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/image_t/tCD007720-CMP-001-18.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Corticosteroids versus no treatment or placebo, Outcome 18 Secondary infections ‐ children." data-id="CD007720-fig-0024" src="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/image_n/nCD007720-CMP-001-18.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.18</div> <div class="figure-caption"> <p>Comparison 1 Corticosteroids versus no treatment or placebo, Outcome 18 Secondary infections ‐ children. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/references#CD007720-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/image_n/nCD007720-CMP-001-18.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007720-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/urn:x-wiley:14651858:media:CD007720:CD007720-CMP-001-19" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/image_t/tCD007720-CMP-001-19.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Corticosteroids versus no treatment or placebo, Outcome 19 Any adverse events ‐ adults." data-id="CD007720-fig-0025" src="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/image_n/nCD007720-CMP-001-19.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.19</div> <div class="figure-caption"> <p>Comparison 1 Corticosteroids versus no treatment or placebo, Outcome 19 Any adverse events ‐ adults. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/references#CD007720-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/image_n/nCD007720-CMP-001-19.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007720-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/urn:x-wiley:14651858:media:CD007720:CD007720-CMP-001-20" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/image_t/tCD007720-CMP-001-20.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Corticosteroids versus no treatment or placebo, Outcome 20 Hyperglycaemia ‐ adults." data-id="CD007720-fig-0026" src="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/image_n/nCD007720-CMP-001-20.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.20</div> <div class="figure-caption"> <p>Comparison 1 Corticosteroids versus no treatment or placebo, Outcome 20 Hyperglycaemia ‐ adults. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/references#CD007720-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/image_n/nCD007720-CMP-001-20.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007720-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/urn:x-wiley:14651858:media:CD007720:CD007720-CMP-001-21" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/image_t/tCD007720-CMP-001-21.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Corticosteroids versus no treatment or placebo, Outcome 21 Gastrointestinal bleeding ‐ adults." data-id="CD007720-fig-0027" src="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/image_n/nCD007720-CMP-001-21.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.21</div> <div class="figure-caption"> <p>Comparison 1 Corticosteroids versus no treatment or placebo, Outcome 21 Gastrointestinal bleeding ‐ adults. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/references#CD007720-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/image_n/nCD007720-CMP-001-21.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007720-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/urn:x-wiley:14651858:media:CD007720:CD007720-CMP-001-22" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/image_t/tCD007720-CMP-001-22.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Corticosteroids versus no treatment or placebo, Outcome 22 Neuropsychiatric side effects ‐ adults." data-id="CD007720-fig-0028" src="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/image_n/nCD007720-CMP-001-22.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.22</div> <div class="figure-caption"> <p>Comparison 1 Corticosteroids versus no treatment or placebo, Outcome 22 Neuropsychiatric side effects ‐ adults. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/references#CD007720-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/image_n/nCD007720-CMP-001-22.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007720-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/urn:x-wiley:14651858:media:CD007720:CD007720-CMP-001-23" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/image_t/tCD007720-CMP-001-23.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Corticosteroids versus no treatment or placebo, Outcome 23 Adverse cardiac events ‐ adults." data-id="CD007720-fig-0029" src="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/image_n/nCD007720-CMP-001-23.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.23</div> <div class="figure-caption"> <p>Comparison 1 Corticosteroids versus no treatment or placebo, Outcome 23 Adverse cardiac events ‐ adults. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/references#CD007720-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/image_n/nCD007720-CMP-001-23.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007720-fig-0030"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/urn:x-wiley:14651858:media:CD007720:CD007720-CMP-001-24" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/image_t/tCD007720-CMP-001-24.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Corticosteroids versus no treatment or placebo, Outcome 24 Any adverse events ‐ children." data-id="CD007720-fig-0030" src="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/image_n/nCD007720-CMP-001-24.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.24</div> <div class="figure-caption"> <p>Comparison 1 Corticosteroids versus no treatment or placebo, Outcome 24 Any adverse events ‐ children. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/references#CD007720-fig-0030">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/media/CDSR/CD007720/image_n/nCD007720-CMP-001-24.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD007720-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Corticosteroids compared to control for pneumonia</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Corticosteroids compared to control for pneumonia</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> people with community‐acquired pneumonia<br/> <b>Setting:</b> hospitalised patients<br/> <b>Intervention:</b> corticosteroids<br/> <b>Comparison:</b> control (placebo or no treatment) </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with control</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with corticosteroids</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Mortality ‐ adults</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.66<br/> (0.47 to 0.92) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1863<br/> (11 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>82 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>53 per 1000<br/> (38 to 74) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Mortality ‐ adults ‐ severe CAP</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.58<br/> (0.40 to 0.84) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>995<br/> (9 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>131 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>76 per 1000<br/> (52 to 110) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Mortality ‐ adults ‐ non‐severe CAP</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.95<br/> (0.45 to 2.00) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>868<br/> (4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>29 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>28 per 1000<br/> (13 to 58) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Early clinical failure ‐ adults</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.40<br/> (0.23 to 0.70) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1324<br/> (6 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>3 4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>373 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>149 per 1000<br/> (86 to 261) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Early clinical failure ‐ adults ‐ severe CAP</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.32<br/> (0.15 to 0.70) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>419<br/> (5 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊕<br/> HIGH <sup>5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>422 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>135 per 1000<br/> (63 to 296) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Early clinical failure ‐ adults ‐ non‐severe CAP</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.68<br/> (0.56 to 0.83) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>905<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊕<br/> HIGH </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>352 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>240 per 1000<br/> (197 to 292) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Early clinical failure ‐ children</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.41<br/> (0.24 to 0.70) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>88<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊕<br/> HIGH <sup>6 7</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>659 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>270 per 1000<br/> (158 to 461) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CAP</b> : community‐acquired pneumonia; <b>CI:</b> confidence interval; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate quality:</b> We are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low quality:</b> Our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low quality:</b> We have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of the effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Some trials had unclear allocation concealment, which seemed to exaggerate the effect of corticosteroids.<br/> <sup>2</sup>We downgraded quality for imprecision because the 95% CIs overlap no effect and the RR ranged from ‐55% to 100%.<br/> <sup>3</sup>We downgraded quality for inconsistency (I² = 89.3% for this outcome).<br/> <sup>4</sup>Some trials had unclear allocation concealment, however we did not downgrade quality because the effect of intervention remained significant in trials with low and unclear allocation concealment.<br/> <sup>5</sup>We downgraded quality for inconsistency (I² = 74% for this outcome) and upgraded one level for large effect (RR = 0.32).<br/> <sup>6</sup>We downgraded quality for risk of bias (analysis includes two low‐quality trials).<br/> <sup>7</sup>We upgraded quality one level for large effect (RR = 0.41). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Corticosteroids compared to control for pneumonia</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/full#CD007720-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD007720-tbl-0002"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Study definitions for clinical failure and time to cure</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Study name</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Clinical failure definition</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time to clinical cure</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007720-bbs2-0001" title="BlumCA , NigroN , BrielM , SchuetzP , UllmerE , Suter‐WidmerI , et al. Adjunct prednisone therapy for patients with community‐acquired pneumonia: a multicentre, double‐blind, randomised, placebo‐controlled trial. Lancet2015;385(9977):1511‐8. ">Blum 2015</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Number of participants not reaching clinical stability on day 5.</p> <p>Clinical stability defined as stable vital signs for ≥ 24 hours. Stable vital signs were temperature of ≤ 37.8 °C, heart rate of ≤ 100 beats per min, spontaneous respiratory rate of ≤ 24 breaths per min, systolic blood pressure of ≥ 90 mm Hg (≥ 100 mm Hg for participants with hypertension) without vasopressor support, mental status back to level before occurrence of community‐acquired pneumonia, ability for oral intake, and adequate oxygenation on room air (PaO₂ ≥ 60 mm Hg or pulse oximetry ≥ 90%). </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time to clinical stability defined as stable vital signs for ≥ 24 hours.</p> <p>Stable vital signs were temperature of ≤ 37.8 °C, heart rate of ≤ 100 beats per min, spontaneous respiratory rate of ≤ 24 breaths per min, systolic blood pressure of ≥ 90 mm Hg (≥ 100 mm Hg for participants with hypertension) without vasopressor support, mental status back to level before occurrence of community‐acquired pneumonia, ability for oral intake, and adequate oxygenation on room air (PaO₂ ≥ 60 mm Hg or pulse oximetry ≥ 90%). </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007720-bbs2-0002" title="ConfalonieriM , UrbinoR , PotenaA , PiattellaM , ParigiP , PuccioG . Hydrocortisone infusion for severe community‐acquired pneumonia: a preliminary randomised study. American Journal of Respiratory and Critical Care Medicine2005;171(3):242‐8. ">Confalonieri 2005</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Number of participants not achieving PaO₂:FiO₂ improvement ≥ 100 mm Hg compared to study entry, evaluated at day 8 </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time to weaning from mechanical ventilation</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007720-bbs2-0003" title="El‐GhamrawyAH , ShokierMH , EsmatAA . Effects of low‐dose hydrocortisone in ICU patients with severe community‐acquired pneumonia. Egyptian Journal of Chest Diseases and Tuberculosis2006;55:91‐9. ">El‐Ghamrawy 2006</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not evaluated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time to weaning from mechanical ventilation</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007720-bbs2-0004" title="Fernández‐SerranoS , DorcaJ , Garcia‐VidalC , Fernández‐SabéN , CarratalàJ , Fernández‐AgüeraA , et al. Effect of corticosteroids on the clinical course of community‐acquired pneumonia: a randomized controlled trial. Critical Care2011;15(2):R96. ">Fernández‐Serrano 2011</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not evaluated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time to resolution of morbidity score, a semi‐quantitative score combining clinical and radiological variables (not detailed in the manuscript but reference provided) </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007720-bbs2-0006" title="LuoZ , LuoJ , LiuE , XuX , LiuY , ZengF , et al. Effects of prednisolone on refractory Mycoplasma pneumoniae pneumonia in children. Pediatric Pulmonology2014;49(4):377‐80. ">Luo 2014</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Number of participants with no infiltrate resolution at day 7</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time to resolution of hypoxaemia</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007720-bbs2-0011" title="NafaeRM , RagabMI , AmanyFM , RashedSB . Adjuvant role of corticosteroids in the treatment of community‐acquired pneumonia. Egyptian Journal of Chest Diseases and Tuberculosis2013;62(3):439–45. ">Nafae 2013</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Number of participants with no improvement at day 7 (improvement definition not provided)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time to weaning from mechanical ventilation</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007720-bbs2-0012" title="NagyB , GasparI , PappA , BeneZ , NagyBJr , VokoZ , et al. Efficacy of methylprednisolone in children with severe community acquired pneumonia. Pediatric Pulmonology2013;48(2):168‐75. ">Nagy 2013</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Number of participants not improving based on clinical and radiological status on day 7 </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time to fever resolution</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007720-bbs2-0010" title="MikamiK , SuzukiM , KitagawaH , KawakamiM , HirotaN , YamaguchiH . Efficacy of corticosteroids in the treatment of community‐acquired pneumonia requiring hospitalisation. Lung2007;185(5):249‐55. ">Mikami 2007</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not evaluated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time to fever resolution</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007720-bbs2-0013" title="SabryNA , OmarEE . Corticosteroids and ICU course of community acquired pneumonia in Egyptian settings. Pharmacology &amp; Pharmacy2011;2:73‐81. [DOI: 10.4236/pp.2011.22009] ">Sabry 2011</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Number of participants not achieving PaO₂:FiO₂ improvement ≥ 100 mm Hg compared to study entry, evaluated at day 8 </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time to weaning from mechanical ventilation</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007720-bbs2-0014" title="SnijdersD , DanielsJM , deGraaffCS , van derWerfTS , BoersmaWG . Efficacy of corticosteroids in community‐acquired pneumonia: a randomized double‐blinded clinical trial. American Journal of Respiratory and Critical Care Medicine2010;181(9):975‐82. ">Snijders 2010</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Number of participants with clinical failure at day 7.</p> <p>Clinical failure defined as: persistence or progression of all signs and symptoms that developed during the acute disease episode after randomisation, or the development of a new pulmonary or extrapulmonary infection, or the deterioration of chest radiography after randomisation, or death due to pneumonia, or the inability to complete the study owing to adverse events. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time to clinical stability defined as when all 4 of the following criteria were met: improvement of cough and shortness of breath, temperature &lt; 37.8 °C for at least 8 hours, declining serum C‐reactive protein levels, and adequate oral intake and gastrointestinal absorption. </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007720-bbs2-0015" title="TorresA , SibilaO , FerrerM , PolverinoE , MenendezR , MensaJ , et al. Effect of corticosteroids on treatment failure among hospitalized patients with severe community‐acquired pneumonia and high inflammatory response: a randomized clinical trial. JAMA2015;313(7):677‐86. ">Torres 2015</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Number of participants with treatment failure between 72 hours and 120 hours after treatment initiation.<br/> Treatment failure defined as radiographic progression (increase of ≥ 50% of pulmonary infiltrates compared with baseline), persistence of severe respiratory failure (PaO₂:FiO₂ &lt; 200 mm Hg, with respiratory rate ≥ 30 breaths/min in participants not intubated), development of shock, need for invasive mechanical ventilation not present at baseline, or death. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time to clinical stability defined as when all of the following criteria were met: temperature ≤ 37.2 °C, heart rate ≤ 100 beats/min, systolic blood pressure ≥ 90 mm Hg, and arterial oxygen tension ≥ 60 mm Hg when the participant was not receiving supplemental oxygen. In participants receiving oxygen therapy at home, stability was considered to be achieved when oxygen needs were the same as before admission. </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007720-bbs2-0016" title="VanWoenselJB , vanAalderenWM , deWeerdW , JansenNJ . Dexamethasone for treatment of patients mechanically ventilated for lower respiratory tract infection caused by respiratory syncytial virus. Thorax2003;58(5):383‐7. ">Van Woensel 2003</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not evaluated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Duration of supplemental oxygen need</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007720-bbs2-0017" title="WuYJ , SunJ , ZhangJH , FengLL . Clinical efficacy of adjuvant therapy with glucocorticoids in children with lobar pneumonia caused by Mycoplasma pneumoniae . Zhongguo Dang Dai Er Ke Za Zhi [Chinese Journal of Contemporary Pediatrics]2014;16(4):401‐5. ">Wu 2014</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not evaluated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time to fever resolution</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="3"> <div class="table-footnote"> <p>FiO₂ = inspired oxygen concentration<br/> PaO₂ = partial pressure of oxygen in arterial blood </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Study definitions for clinical failure and time to cure</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/full#CD007720-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD007720-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Corticosteroids versus no treatment or placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Mortality ‐ adults <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1863</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.66 [0.47, 0.92]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Low risk of bias for allocation concealment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1594</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.80 [0.54, 1.19]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Unclear risk of bias for allocation concealment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>269</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.36 [0.19, 0.71]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Mortality ‐ adults, severe pneumonia, by allocation concealment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>995</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.58 [0.40, 0.84]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Low risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>771</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.72 [0.46, 1.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Unclear risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>224</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.34 [0.17, 0.68]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Mortality ‐ adults, non‐severe pneumonia, by allocation concealment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>868</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.45, 2.00]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Low risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>823</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.44, 2.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Unclear risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>45</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.06, 14.37]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Mortality ‐ children <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>266</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [‐0.03, 0.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Bacterial pneumonia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>225</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [‐0.03, 0.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Viral pneumonia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>41</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [‐0.09, 0.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Early clinical failure ‐ adults <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1324</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.40 [0.23, 0.70]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Severe CAP</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>419</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.32 [0.15, 0.70]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 Non‐severe CAP</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>905</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.68 [0.56, 0.83]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Early clinical failure ‐ children <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>88</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.41 [0.24, 0.70]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Bacterial pneumonia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>88</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.41 [0.24, 0.70]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Early clinical failure ‐ adults + children by allocation concealment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1412</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.40 [0.26, 0.63]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 Low risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1164</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.59 [0.37, 0.94]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2 Unclear risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>248</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.27 [0.14, 0.52]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Time to clinical cure ‐ adults <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1322</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.83 [‐2.45, ‐1.21]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Time to clinical cure ‐ children <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.1 Bacterial pneumonia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>225</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.57 [‐2.55, ‐0.60]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.2 Viral pneumonia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>41</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.70 [‐2.50, 5.90]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Need for mechanical ventilation ‐ adults <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1030</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.40 [0.20, 0.77]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Development of shock ‐ adults <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>415</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.18 [0.09, 0.34]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Need for ICU transfer ‐ adults <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1164</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.73 [0.45, 1.18]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Length of hospitalisation ‐ adults <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1658</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.91 [‐4.92, ‐0.89]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14 Length of ICU stay ‐ adults <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>342</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.88 [‐2.96, ‐0.81]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">15 Length of hospitalisation ‐ children <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>15.1 Bacterial pneumonia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>15.2 Viral pneumonia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">16 Pneumonia complications ‐ adults + children <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1632</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.58 [0.40, 0.84]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">17 Secondary infections ‐ adults <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1533</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.19 [0.73, 1.93]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">18 Secondary infections ‐ children <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>225</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [‐0.03, 0.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>18.1 Bacterial pneumonia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>225</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [‐0.03, 0.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">19 Any adverse events ‐ adults <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1028</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.21 [0.99, 1.47]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">20 Hyperglycaemia ‐ adults <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1578</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.72 [1.38, 2.14]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">21 Gastrointestinal bleeding ‐ adults <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1190</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.91 [0.40, 2.05]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">22 Neuropsychiatric side effects ‐ adults <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1149</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.95 [0.70, 5.42]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">23 Adverse cardiac events ‐ adults <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1249</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.60 [0.32, 1.13]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">24 Any adverse events ‐ children <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>24.1 Bacterial pneumonia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>117</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [‐0.05, 0.05]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Corticosteroids versus no treatment or placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007720.pub3/references#CD007720-tbl-0003">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD007720.pub3&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD007720-note-0003">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD007720-note-0006">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD007720-note-0002">Français</a> </li> <li class="section-language"> <a class="" href="ms#CD007720-note-0011">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pt#CD007720-note-0004">Português</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD007720-note-0001">繁體中文</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD007720-note-0005">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007720\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007720\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007720\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD007720\x2epub3"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007720\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007720\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007720\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007720\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007720\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD007720\x2epub3"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007720\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007720\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007720\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD007720\x2epub3"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007720\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007720\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007720\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD007720\x2epub3"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=9mpoajSI&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD007720.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD007720.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD007720.pub3/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD007720.pub3/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD007720.pub3%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740728338562"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD007720.pub3/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740728338566"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD007720.pub3/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918ec2093eedf46e',t:'MTc0MDcyODM0MC4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 